{"content":"<li class=\"n-box-item date-title\" data-end=\"1389070799\" data-start=\"1388984400\" data-txt=\"Saturday, December 21, 2019\">Monday, January  6, 2014</li><li class=\"n-box-item sa-box-item\" data-id=\"1494171\" data-ts=\"1389049916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBF\" target=\"_blank\">PBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1494171-pbf-energy-in-15m-share-offering-shares-minus-4_7-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PBF Energy in 15M-share offering, shares -4.7% AH</a></h4><ul><li>PBF Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/PBF\" title=\"PBF Energy\">PBF</a>) <font color=\"red\">-4.7%</font> AH after announcing a secondary public offering of 15M common shares by selling shareholders; PBF will receive no proceeds from the offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"1494171\" data-linked=\"PBF Energy in 15M-share offering, shares -4.7% AH\" data-tweet=\"$PBF - PBF Energy in 15M-share offering, shares -4.7% AH https://seekingalpha.com/news/1494171-pbf-energy-in-15m-share-offering-shares-minus-4_7-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1494171-pbf-energy-in-15m-share-offering-shares-minus-4_7-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1494131\" data-ts=\"1389048773\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAT\" target=\"_blank\">USAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1494131-usa-technologies-surges-and-falls-ah-potentially-on-blog-post\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USA Technologies surges and falls AH, potentially on blog post</a></h4><ul><li>USA Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a>) shares surged&nbsp;<font color='green'>27.4%</font>&nbsp;in AH trading before coming back down to&nbsp;<font color='green'>+3.9%</font>&nbsp;AH on top of a&nbsp;<font color='green'>12.4%</font>&nbsp;gain in regular trading.</li><li>The move seems to have been sparked by a <a href=\"http://peterpanstocks.blogspot.com/2014/01/usat-will-it-triple-in-2014.html\" target=\"_blank\">blog post</a> yesterday which made a technical-based bull case for the electronic payment name.</li></ul><div class=\"tiny-share-widget\" data-id=\"1494131\" data-linked=\"USA Technologies surges and falls AH, potentially on blog post\" data-tweet=\"$USAT - USA Technologies surges and falls AH, potentially on blog post https://seekingalpha.com/news/1494131-usa-technologies-surges-and-falls-ah-potentially-on-blog-post?source=tweet\" data-url=\"https://seekingalpha.com/news/1494131-usa-technologies-surges-and-falls-ah-potentially-on-blog-post\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1494111\" data-ts=\"1389048000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNXL\" target=\"_blank\">UNXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1494111-unipixel-delays-intouch-sensor-production-to-q2-shares-minus-5_4-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniPixel delays InTouch sensor production to Q2, shares -5.4% AH</a></h4><ul>\n<li>UniPixel (NASDAQ:<a href=\"https://seekingalpha.com/symbol/UNXL\" title=\"Uni-Pixel, Inc.\">UNXL</a>) has delayed the \"manufacturing ramp\" for its InTouch metal mesh sensors to Q2 2014. The company <a href=\"https://seekingalpha.com/news/1311172-UniPixel-jumps-following-bullish-CC\" target=\"_blank\">once promised</a> InTouch production would start in Q4.</li>\n<li>UniPixel says it provided \"hundreds of [InTouch] samples and demonstration units to key potential customers\" in 2013, but didn't fulfill any \"commercial production orders.\" The company declares the planned arrival of testing/measurement equipment in January will accelerate its manufacturing efforts.</li>\n<li>The announcement comes a week after UniPixel announced the resignation of CEO <a href=\"https://seekingalpha.com/news/1486121-UniPixel-CEO-resigns-shares-minus-3_4-percent-AH\" target=\"_blank\">Reed Killion</a> and COO <a href=\"https://seekingalpha.com/news/1487471-UniPixel-COO-joins-CEO-in-departing-shares-minus-5-percent-AH\" target=\"_blank\">Peter Shin</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1494111\" data-linked=\"UniPixel delays InTouch sensor production to Q2, shares -5.4% AH\" data-tweet=\"$UNXL - UniPixel delays InTouch sensor production to Q2, shares -5.4% AH https://seekingalpha.com/news/1494111-unipixel-delays-intouch-sensor-production-to-q2-shares-minus-5_4-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1494111-unipixel-delays-intouch-sensor-production-to-q2-shares-minus-5_4-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1494101\" data-ts=\"1389047922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1494101-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5:15 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/CVG\" title=\"Convergys Corporation\">CVG</a> <font color=\"green\">+19.9%</font>. <a href=\"https://seekingalpha.com/symbol/USAT\" title=\"USA Technologies, Inc.\">USAT</a> <font color=\"green\">+18.8%</font>. <a href=\"https://seekingalpha.com/symbol/SHLM\" title=\"A. Schulman, Inc.\">SHLM</a> <font color=\"green\">+6.9%</font>. <a href=\"https://seekingalpha.com/symbol/VRS\" title=\"Verso Corporation\">VRS</a> <font color=\"green\">+5.3%</font>. <a href=\"https://seekingalpha.com/symbol/SEED\" title=\"Origin Agritech Limited\">SEED</a> <font color=\"green\">+5.1%</font>.</li>\n<li>\n<b>Top losers, as of 5:15 p.m.:</b> CYNI <font color=\"red\">-22.4%</font>. <a href=\"https://seekingalpha.com/symbol/PKY\" title=\"Parkway Properties Inc.\">PKY</a> <font color=\"red\">-3.5%</font>. <a href=\"https://seekingalpha.com/symbol/NYMT\" title=\"New York Mortgage Trust, Inc.\">NYMT</a> <font color=\"red\">-3.4%</font>. <a href=\"https://seekingalpha.com/symbol/KW\" title=\"Kennedy-Wilson Holdings, Inc.\">KW</a> <font color=\"red\">-3.1%</font>. <a href=\"https://seekingalpha.com/symbol/PLAB\" title=\"Photronics, Inc.\">PLAB</a> <font color=\"red\">-2.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1494101\" data-linked=\"After hours Gainers / Losers\" data-tweet=\"$CVG $USAT $SHLM - After hours Gainers / Losers https://seekingalpha.com/news/1494101-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1494101-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1494091\" data-ts=\"1389047207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PALDF\" target=\"_blank\">PALDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1494091-north-american-palladium-plus-16-percent-after-strong-lac-des-iles-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">North American Palladium +16% after strong Lac des Iles guidance</a></h4><ul>     <li>North American Palladium (PAL) <font color=\"green\">+16.6%</font> AH after releasing its 2014 production guidance along with capital expenditure and exploration forecasts for its Lac des Iles palladium mine.</li>     <li>PAL continues to estimate 2013 LDI payable palladium production totaling ~135K oz. and is targeting 2014 output of 170K-175K oz.; underground mining is expected to average ~3K metric tons/day for H1 2014 and rise to 5K by year-end.</li>     <li>Capital investment and exploration budgets are significantly reduced to ~$30M and $4M, respectively.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1494091\" data-linked=\"North American Palladium +16% after strong Lac des Iles guidance\" data-tweet=\"$PALDF - North American Palladium +16% after strong Lac des Iles guidance https://seekingalpha.com/news/1494091-north-american-palladium-plus-16-percent-after-strong-lac-des-iles-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1494091-north-american-palladium-plus-16-percent-after-strong-lac-des-iles-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1494041\" data-ts=\"1389045057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALL\" target=\"_blank\">CALL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1494041-magicjack-rallies-strongly-following-canaccord-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">magicJack rallies strongly following Canaccord launch</a></h4><ul><li>magicJack (<a href='https://seekingalpha.com/symbol/CALL' title='magicJack VocalTec Communications Ltd.'>CALL</a> <font color='green'>+6.7%</font>) managed to hit levels last seen in October after Canaccord started coverage with a Buy and $17 PT.</li><li>Shares jumped in November after the company posted Q3 results and <a href=\"https://seekingalpha.com/news/1409752-magicJack-jumps-after-posting-Q3-results-announcing-founders-departure\" target=\"_blank\">cut all ties</a> with controversial founder Daniel Borislow.</li><li>5.5M shares (a full 52% of the float) were shorted as of Dec. 13; that was the highest level recorded in all of 2013.</li></ul><div class=\"tiny-share-widget\" data-id=\"1494041\" data-linked=\"magicJack rallies strongly following Canaccord launch\" data-tweet=\"$CALL - magicJack rallies strongly following Canaccord launch https://seekingalpha.com/news/1494041-magicjack-rallies-strongly-following-canaccord-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/1494041-magicjack-rallies-strongly-following-canaccord-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1494001\" data-ts=\"1389044521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPEX\" target=\"_blank\">SPEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1494001-spherix-plus-6_1-percent-ah-withdraws-50m-mixed-sminus-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spherix +6.1% AH, withdraws $50M mixed S-3</a></h4><ul><li>Spherix (NASDAQ:<a href='https://seekingalpha.com/symbol/SPEX' title='Spherix Incorporated'>SPEX</a>) shares&nbsp;<font color='green'>jump 6.1%</font>&nbsp;AH following the company's withdrawal (<a href=\"http://www.sec.gov/Archives/edgar/data/12239/000141588914000039/spexrwjan62014.htm\" target=\"_blank\">RW</a>) of its $50M mixed <a href=\"http://www.sec.gov/Archives/edgar/data/12239/000141588913000473/spexs3mar182013.htm\" target=\"_blank\">S-3</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1494001\" data-linked=\"Spherix +6.1% AH, withdraws $50M mixed S-3\" data-tweet=\"$SPEX - Spherix +6.1% AH, withdraws $50M mixed S-3 https://seekingalpha.com/news/1494001-spherix-plus-6_1-percent-ah-withdraws-50m-mixed-sminus-3?source=tweet\" data-url=\"https://seekingalpha.com/news/1494001-spherix-plus-6_1-percent-ah-withdraws-50m-mixed-sminus-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493991\" data-ts=\"1389044314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493991-cyan-minus-22_6-percent-preliminary-q4-revenue-of-20m-21m-short-of-guidance-by-a-third\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cyan -22.6%, preliminary Q4 revenue of $20M-$21M short of guidance by a third</a></h4><ul>\n<li>Cyan (CYNI) shares crater 22.6% AH following the company's preliminary revenue announcement of $20M-$21M, miles below the previous $30M-$33M guidance and analyst expectations of $31.3M.</li>\n<li>The company attributed the decline to an 88% Q/Q decrease in revenue from its largest customer to $2M.</li>\n<li>a silver lining: revenue on the year expanded 32%-34% Y/Y to $70M-$71M excluding the largest customer as Cyan diversifies its base.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493991\" data-linked=\"Cyan -22.6%, preliminary Q4 revenue of $20M-$21M short of guidance by a third\" data-tweet=\"$CIEN - Cyan -22.6%, preliminary Q4 revenue of $20M-$21M short of guidance by a third https://seekingalpha.com/news/1493991-cyan-minus-22_6-percent-preliminary-q4-revenue-of-20m-21m-short-of-guidance-by-a-third?source=tweet\" data-url=\"https://seekingalpha.com/news/1493991-cyan-minus-22_6-percent-preliminary-q4-revenue-of-20m-21m-short-of-guidance-by-a-third\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493971\" data-ts=\"1389043893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLR\" target=\"_blank\">DLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493971-digital-realty-provides-q4-leasing-activity-updates-2014-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Realty provides Q4 leasing activity; updates 2014 guidance</a></h4><ul>\n<li>The company signed new leases totaling more than $50M of annualized GAAP rent during Q4, bringing the YTD total to more than $160M - both records for the company.</li>\n<li>2014 FFO per share guidance is for $4.75-$4.90, with assumptions today largely unchanged from the company's preliminary 2014 outlook released at the end of October - it was then the company guided to FFO growth in the mid-single digits starting from a base of $4.60.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/DLR\" title=\"Digital Realty Trust, Inc.\">DLR</a> <font color=\"green\">+1.6%</font> AH</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493971\" data-linked=\"Digital Realty provides Q4 leasing activity; updates 2014 guidance\" data-tweet=\"$DLR - Digital Realty provides Q4 leasing activity; updates 2014 guidance https://seekingalpha.com/news/1493971-digital-realty-provides-q4-leasing-activity-updates-2014-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1493971-digital-realty-provides-q4-leasing-activity-updates-2014-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493901\" data-ts=\"1389043032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYMT\" target=\"_blank\">NYMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493901-new-york-mortgage-trust-secondary-minus-3_4-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New York Mortgage Trust secondary; -3.4% AH</a></h4><ul>\n<li>New York Mortgage Trust (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NYMT\" title=\"New York Mortgage Trust, Inc.\">NYMT</a>) takes advantage of its premium pricing (one of the few if not only stocks in the mREIT sector not trading at  discount to book value), launching a 10M share secondary with underwriter greenshoe of 1.5M shares.</li>\n<li>The stock's<font color=\"red\"> off 3.4%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493901\" data-linked=\"New York Mortgage Trust secondary; -3.4% AH\" data-tweet=\"$NYMT - New York Mortgage Trust secondary; -3.4% AH https://seekingalpha.com/news/1493901-new-york-mortgage-trust-secondary-minus-3_4-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1493901-new-york-mortgage-trust-secondary-minus-3_4-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493861\" data-ts=\"1389042589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBIX\" target=\"_blank\">NBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493861-neurocrine-biosciences-hits-endpoint-in-tardive-dyskinesia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neurocrine Biosciences hits endpoint in tardive dyskinesia</a></h4><ul>\n<li>Neurocrine Biosciences (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NBIX\" title=\"Neurocrine Biosciences, Inc.\">NBIX</a>) jumps <font color=\"green\">43%</font> AH as the company says the small molecule VMAT2 inhibitor NBI-98854 hit its primary endpoint in Kinect 2.</li>\n<li>Week 6 AIMS scores: -2.6 points for the ITT group and -0.2 points for placebo \u2014 that's good for p&lt;0.001.</li>\n<li>Responder rate: 49% versus 18% in placebo for p&lt;0.002.</li>\n<li>\"The profound response in this Kinect 2 study demonstrates the potential  of NBI-98854 as both a safe and highly effective treatment for patients  suffering from tardive dyskinesia,\" the company notes.</li>\n<li>NBIX will now finalize the initial draft for Phase 3 protocol which it expects to file in H1. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493861\" data-linked=\"Neurocrine Biosciences hits endpoint in tardive dyskinesia\" data-tweet=\"$NBIX - Neurocrine Biosciences hits endpoint in tardive dyskinesia https://seekingalpha.com/news/1493861-neurocrine-biosciences-hits-endpoint-in-tardive-dyskinesia?source=tweet\" data-url=\"https://seekingalpha.com/news/1493861-neurocrine-biosciences-hits-endpoint-in-tardive-dyskinesia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493821\" data-ts=\"1389042254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHCAY\" target=\"_blank\">SHCAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493821-universal-display-slumps-galaxy-s5-to-reportedly-use-lcds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Display slumps; Galaxy S5 to reportedly use LCDs</a></h4><ul>\n<li>A Chinese site reports (<a href=\"http://mobile.it168.com/a2014/0105/1582/000001582606.shtml\" target=\"_blank\">translation</a>) Samsung is <a href=\"http://bgr.com/2014/01/06/galaxy-s5-specs-2k-display-ltps/\" target=\"_blank\">having trouble</a> mass-producing Super AMOLED displays featuring 2K (2560x1440) resolutions for the Galaxy S5, and has thus decided to have its next-gen flagship phone use Sharp (<a href=\"https://seekingalpha.com/symbol/SHCAY\" title=\"Sharp Corp. ADR\">OTCPK:SHCAY</a>) LCDs.</li>\n<li>Universal Display (<a href=\"https://seekingalpha.com/symbol/OLED\" title=\"Universal Display Corporation\">OLED</a> <font color=\"red\">-2.4%</font>), which gets over half its revenue from Samsung, sold off in afternoon trading thanks to the report. The relatively moderate size of the drop suggests investors have their doubts about the report.</li>\n<li>Ramping sales to Samsung - particularly sales of green host/emitter materials for the Galaxy S4 and other high-end Samsung smartphones - allowed Universal to post <a href=\"https://seekingalpha.com/news/1398822-Universal-Display-plus-17_9-percent-AH-following-Q3-beat-strong-guidance\" target=\"_blank\">triple-digit</a> materials revenue growth in Q3.</li>\n<li>Samsung <a href=\"https://seekingalpha.com/news/1420201-Samsung-smartwatch-sales-reach-800K-gets-ambitious-with-displays\" target=\"_blank\">announced in November</a> it plans to launch phones with 2K displays in 2014, and phones with 4K displays in 2015. There's <a href=\"https://twitter.com/vladsavov/status/398086365142740993\" target=\"_blank\">plenty of skepticism </a>regarding the practical value of placing such high-res displays on smartphones.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493821\" data-linked=\"Universal Display slumps; Galaxy S5 to reportedly use LCDs\" data-tweet=\"$SHCAY $SHCAY $OLED - Universal Display slumps; Galaxy S5 to reportedly use LCDs https://seekingalpha.com/news/1493821-universal-display-slumps-galaxy-s5-to-reportedly-use-lcds?source=tweet\" data-url=\"https://seekingalpha.com/news/1493821-universal-display-slumps-galaxy-s5-to-reportedly-use-lcds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493711\" data-ts=\"1389040219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVAC\" target=\"_blank\">PVAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493711-penn-virginia-plus-8_6-percent-as-suntrust-calls-it-a-top-takeover-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Penn Virginia +8.6% as SunTrust calls it a &quot;top takeover target&quot;</a></h4><ul>     <li>Penn Virginia (PVA <font color=\"green\">+8.6%</font>) pops nearly 10% today after SunTrust calls it a \u201c<a href=\"http://blogs.barrons.com/stockstowatchtoday/2014/01/06/penn-virginia-10-today-100-tomorrow\" target=\"_blank\">top takeover target this year</a>\u201d and names it as a top pick, praising its operational excellence and citing various catalysts.</li>     <li>Devon Energy's <a href=\"https://seekingalpha.com/news/1422671-Devon-Energy-confirms-6B-deal-for-GeoSoutherns-Eagle-Ford-assets\" target=\"_blank\">recent acquisition</a> of nearby Eagle Ford shale assets for $6B highlights PVA's value, the firm says, calculating that if all acreage was the same, PVA trades at ~25% of the value of the latest acquisition, and nearly as large a discount even after taking into account some acreage differences.</li>\n<li>SunTrust sees PVA powering higher to $18, nearly double Friday's closing price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1493711\" data-linked=\"Penn Virginia +8.6% as SunTrust calls it a &quot;top takeover target&quot;\" data-tweet=\"$PVAC - Penn Virginia +8.6% as SunTrust calls it a &quot;top takeover target&quot; https://seekingalpha.com/news/1493711-penn-virginia-plus-8_6-percent-as-suntrust-calls-it-a-top-takeover-target?source=tweet\" data-url=\"https://seekingalpha.com/news/1493711-penn-virginia-plus-8_6-percent-as-suntrust-calls-it-a-top-takeover-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493701\" data-ts=\"1389039831\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493701-sterne-automotive-mulally-staying-put\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sterne Automotive: Mulally staying put</a></h4><ul>\n<li>Microsoft (<a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a> <font color=\"red\">-2%</font>) takes on a little more water in afternoon action as a Sterne Automotive analyst says Ford's (<a href=\"https://seekingalpha.com/symbol/F\" title=\"Ford Motor Company\">F</a> <font color=\"green\">+0.6%</font>) board meets on Wednesday and is likely <a href=\"https://twitter.com/thenotablecalls/status/420285809959268353\" target=\"_blank\">to provide an update</a> regarding the future of CEO Alan Mulally. In the Sterne team's opinion, Mulally isn't going anywhere.</li>\n<li>Previous: <a href=\"https://seekingalpha.com/news/1472191\" target=\"_blank\">Doubts grow over Mulally</a> candidacy due to his lack of technical background.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493701\" data-linked=\"Sterne Automotive: Mulally staying put\" data-tweet=\"$MSFT $MSFT $F - Sterne Automotive: Mulally staying put https://seekingalpha.com/news/1493701-sterne-automotive-mulally-staying-put?source=tweet\" data-url=\"https://seekingalpha.com/news/1493701-sterne-automotive-mulally-staying-put\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493671\" data-ts=\"1389039169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNI\" target=\"_blank\">GNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493671-great-northern-iron-ore-minus-43-percent-on-negative-seeking-alpha-article\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Northern Iron Ore -43% on negative Seeking Alpha article</a></h4><ul>     <li>Great Northern Iron Ore (<a href=\"https://seekingalpha.com/symbol/GNI\" title=\"Great Northern Iron Ore Properties\">GNI</a> <font color=\"red\">-43.2%</font>) is cut nearly in half as Seeking Alpha contributor Night Heron says shares <a href=\"https://seekingalpha.com/article/1928511-Great-Northern-Iron-Now-Worth-Less-Than-21-Will-Fall-To-0-In-15-Months\" target=\"_blank\">will fall to zero</a> within 15 months.</li>\n<li>Buyers are being misled by stories highlighting GNI's 15% dividend yield, but GNI is a royalty trust that, according to its own website, <a href=\"http://www.gniop.com/termination.html\" target=\"_blank\">will terminate</a> - worthless - on April 5, 2015; only five quarterly dividends plus a final distribution will be paid prior to termination, the author writes.</li>\n<li>Remaining distributions will total ~$21; \"it certainly doesn't make  sense to pay any more than that,\" Night Heron says, yet shares are selling for $67.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1493671\" data-linked=\"Great Northern Iron Ore -43% on negative Seeking Alpha article\" data-tweet=\"$GNI - Great Northern Iron Ore -43% on negative Seeking Alpha article https://seekingalpha.com/news/1493671-great-northern-iron-ore-minus-43-percent-on-negative-seeking-alpha-article?source=tweet\" data-url=\"https://seekingalpha.com/news/1493671-great-northern-iron-ore-minus-43-percent-on-negative-seeking-alpha-article\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493601\" data-ts=\"1389037525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PKI\" target=\"_blank\">PKI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493601-perkinelmer-rallies-on-cowen-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PerkinElmer rallies on Cowen upgrade</a></h4><ul>\n<li>PerkinElmer (<a href=\"https://seekingalpha.com/symbol/PKI\" title=\"PerkinElmer, Inc.\">PKI</a> <font color=\"green\">+1.5%</font>) gets <a href=\"http://www.streetinsider.com/Analyst+PT+Change/Cowen+Upgrades+PerkinElmer+%28PKI%29+to+Outperform/9025722.html\" target=\"_blank\">an upgrade</a> to Outperform from Market Perform at Cowen.</li>\n<li>Price target lifted to $47 from $35.20.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493601\" data-linked=\"PerkinElmer rallies on Cowen upgrade\" data-tweet=\"$PKI - PerkinElmer rallies on Cowen upgrade https://seekingalpha.com/news/1493601-perkinelmer-rallies-on-cowen-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1493601-perkinelmer-rallies-on-cowen-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493571\" data-ts=\"1389036732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ODP\" target=\"_blank\">ODP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493571-tough-trends-of-office-supply-chains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tough trends of office supply chains</a></h4><ul> <li>Shares of Office Depot (<a href=\"https://seekingalpha.com/symbol/ODP\" title=\"Office Depot Inc.\">ODP</a> <font color=\"red\">-6.8%</font>) and Staples (<a href=\"https://seekingalpha.com/symbol/SPLS\" title=\"Staples, Inc.\">SPLS</a> <font color=\"red\">-2.7%</font>) trade weak as some of the <a href=\"https://seekingalpha.com/news/1493051-Best-Buy-slumps-after-sector-margin-warning\" target=\"_blank\">same concerns</a> that have hit hhgregg and Best Buy on electronics pricing appear relevant to the office supply chains.</li> <li>Even before the widespread winter storms of the lat few days, channel checks were pointing toward weak traffic trends for the two companies.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1493571\" data-linked=\"Tough trends of office supply chains\" data-tweet=\"$ODP $ODP $SPLS - Tough trends of office supply chains https://seekingalpha.com/news/1493571-tough-trends-of-office-supply-chains?source=tweet\" data-url=\"https://seekingalpha.com/news/1493571-tough-trends-of-office-supply-chains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493561\" data-ts=\"1389036385\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNA\" target=\"_blank\">RNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493561-prosensa-notably-higher-on-the-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prosensa notably higher on the day</a></h4><ul>\n<li>Shares of Prosensa (<a href=\"https://seekingalpha.com/symbol/RNA\" title=\"Prosensa Holding N.V.\">RNA</a> <font color=\"green\">+6.4%</font>) are higher on the session.</li>\n<li>Investors may be reacting to Adam Feuerstein's <a href=\"http://www.thestreet.com/story/12211040/1/this-fda-letter-about-sarepta-and-accelerated-approval-for-eteplirsen-will-blow-your-mind.html\" target=\"_blank\">mention of the company</a> in his article regarding the FDA's stance on DMD drugs.</li>\n<li>\"Chew's letter, suggests some wiggle room for the possibility that FDA  would... might... possibly... be willing to review [Sarepta's] eteplirsen based on  the existing phase II data,\" Feuerstein writes, before saying that \"the same could be said for [RNA] and <a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a>'s <a href=\"https://seekingalpha.com/currents/search?query=drisapersen\" target=\"_blank\">drisapersen</a>, if the companies decide to submit data from the failed Phase 3 study.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493561\" data-linked=\"Prosensa notably higher on the day\" data-tweet=\"$RNA $RNA $GSK - Prosensa notably higher on the day https://seekingalpha.com/news/1493561-prosensa-notably-higher-on-the-day?source=tweet\" data-url=\"https://seekingalpha.com/news/1493561-prosensa-notably-higher-on-the-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493551\" data-ts=\"1389035734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VWDRY\" target=\"_blank\">VWDRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493551-vestas-raises-cash-flow-target-shares-plus-6-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vestas raises cash flow target, shares +6%</a></h4><ul>     <li>Vestas Wind Systems (<a href=\"https://seekingalpha.com/symbol/VWDRY\" title=\"Vestas Wind Systems A/S ADR\">OTCPK:VWDRY</a> <font color=\"green\">+6%</font>) <a href=\"http://www.ft.com/intl/cms/s/0/a333bf5a-76f4-11e3-a253-00144feabdc0.html#axzz2pe5aVxaV\" target=\"_blank\">raises its cash flow target for the third time in a year</a>, as the wind turbine manufacturer shows further signs that its recovery is taking hold.</li>     <li>Vestas says its free cash flow last year would total ~\u20ac1B vs. a previous forecast of \u20ac500M-\u20ac700M and a year ago expecting cash flow just above zero.</li>\n<li>Vestas enjoyed one of its busiest-ever months for orders in December as it unveiled a number of large U.S. deals involving more than 400 turbines from the likes of Enel Green Power and First Wind.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493551\" data-linked=\"Vestas raises cash flow target, shares +6%\" data-tweet=\"$VWDRY - Vestas raises cash flow target, shares +6% https://seekingalpha.com/news/1493551-vestas-raises-cash-flow-target-shares-plus-6-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1493551-vestas-raises-cash-flow-target-shares-plus-6-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493531\" data-ts=\"1389035388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCK\" target=\"_blank\">MCK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493531-healthcare-upgrades-for-monday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare upgrades for Monday</a></h4><ul>\n<li>McKesson (<a href=\"https://seekingalpha.com/symbol/MCK\" title=\"McKesson Corporation\">MCK</a> <font color=\"red\">-0.1%</font>) <a href=\"http://www.streetinsider.com/news.php?id=9024739\" target=\"_blank\">upgraded</a> to Strong Buy from Outperform at Raymond James.</li>\n<li>DaVita (<a href=\"https://seekingalpha.com/symbol/DVA\" title=\"DaVita HealthCare Partners Inc.\">DVA</a> <font color=\"green\">+0.4%</font>) <a href=\"http://www.streetinsider.com/news.php?id=9025475\" target=\"_blank\">upgraded</a> to Outperform from Market Perform at Raymond James.</li>\n<li>Idenix Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/IDIX\" title=\"Idenix Pharmaceuticals, Inc.\">IDIX</a> <font color=\"red\">-0.3%</font>) <a href=\"http://www.streetinsider.com/news.php?id=9025839\" target=\"_blank\">upgraded</a> to Buy from Neutral at UBS.</li>\n<li>Abbott Labs (<a href=\"https://seekingalpha.com/symbol/ABT\" title=\"Abbott Laboratories\">ABT</a> <font color=\"green\">+1.5%</font>) <a href=\"http://www.streetinsider.com/news.php?id=9024569\" target=\"_blank\">upgraded</a> to Overweight from Equalweight at Morgan Stanley.</li>\n<li>Medtronic (<a href=\"https://seekingalpha.com/symbol/MDT\" title=\"Medtronic plc\">MDT</a> <font color=\"green\">+2%</font>) <a href=\"http://www.streetinsider.com/news.php?id=9024746\" target=\"_blank\">upgraded</a> to Overweight from Neutral at JPMorgan. Price target is $69.</li>\n<li>Vertex Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/VRTX\" title=\"Vertex Pharmaceuticals Incorporated\">VRTX</a> <font color=\"green\">+2.5%</font>) <a href=\"http://www.streetinsider.com/news.php?id=9024804\" target=\"_blank\">upgraded</a> to Buy from Neutral at UBS.</li>\n<li>Ocera Therapeutics (<a href=\"https://seekingalpha.com/symbol/OCRX\" title=\"Ocera Therapeutics, Inc.\">OCRX</a> <font color=\"green\">+2.7%</font>) <a href=\"http://www.streetinsider.com/news.php?id=9026109\" target=\"_blank\">upgraded</a> to Outperform from Market Perform at BMO.</li>\n<li>Boston Scientific (<a href=\"https://seekingalpha.com/symbol/BSX\" title=\"Boston Scientific Corporation\">BSX</a> <font color=\"green\">+3.2%</font>) <a href=\"http://www.streetinsider.com/news.php?id=9024605\" target=\"_blank\">upgraded</a> to Overweight from Equalweight at Morgan Stanley.</li>\n<li>Exelixis (<a href=\"https://seekingalpha.com/symbol/EXEL\" title=\"Exelixis, Inc.\">EXEL</a> <font color=\"green\">+4.6%</font>) <a href=\"http://www.streetinsider.com/news.php?id=9025257\" target=\"_blank\">upgraded</a> to Overweight from Neutral at Piper.</li>\n<li>St. Jude Medical (<a href=\"https://seekingalpha.com/symbol/STJ\" title=\"St. Jude Medical, Inc.\">STJ</a> <font color=\"green\">+3.8%</font>) <a href=\"http://www.streetinsider.com/news.php?id=9024793\" target=\"_blank\">upgraded</a> to Overweight from Equalweight at Morgan Stanley.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493531\" data-linked=\"Healthcare upgrades for Monday\" data-tweet=\"$MCK $MCK $DVA - Healthcare upgrades for Monday https://seekingalpha.com/news/1493531-healthcare-upgrades-for-monday?source=tweet\" data-url=\"https://seekingalpha.com/news/1493531-healthcare-upgrades-for-monday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493501\" data-ts=\"1389034955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493501-facebook-higher-following-pt-hike-wsj-details-zucks-transformation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook higher following PT hike; WSJ details Zuck&#39;s transformation</a></h4><ul>\n<li>SunTrust's <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/14/01/4194220/suntrust-raises-facebook-pt-and-estimates-on-increased-o\" target=\"_blank\">Robert Peck</a> has hiked his Facebook (<a href=\"https://seekingalpha.com/symbol/FB\" title=\"Facebook\">FB</a> <font color=\"green\">+3.4%</font>) PT to $65 from $55 (<a href=\"https://seekingalpha.com/news/1264272-Facebook-PT-hiked-to-Street-high-55-at-SunTrust\" target=\"_blank\">established</a> in September), citing optimism about a number of ad and engagement  trends.</li>\n<li>Peck thinks concerns about slowing news feed ad load growth (triggered by <a href=\"https://seekingalpha.com/news/1372362-More-on-Facebook-news-feed-ads-ARPUs-international-growth\" target=\"_blank\">Q3 CC remarks</a>) are \"overdone\" in light of <a href=\"https://seekingalpha.com/news/1328922-Facebook-rallies-Evercore-raises-PT-new-ad-product-launched\" target=\"_blank\">improving ad targeting</a> and pricing. He also considers <a href=\"https://seekingalpha.com/news/1418602-Facebook-leads-Web-selloff-NYT-looks-at-popularity-concerns\" target=\"_blank\">teen usage concerns</a> overblown, given Facebook has evolved from being a \"cool app\" to a social utility.</li>\n<li>Peck is enthusiastic about Facebook's Instagram and video ad ramps (he thinks they could add ~$300M in 2014 revenue), and (citing 3rd-party data) believes Facebook and other social apps saw healthy usage trends in Q4.</li>\n<li>Meanwhile, the <em>WSJ</em> has provided a <a href=\"http://online.wsj.com/news/article_email/SB10001424052702303640604579296452086218242-lMyQjAxMTA0MDAwNTEwNDUyWj\" target=\"_blank\">behind-the-scenes look</a> at how Mark Zuckerberg learned to stop worrying and love ad monetization, as his company contended with a rocky 2012 IPO and the mobile shift.</li>\n<li>\"If you brought up revenue in an argument with Zuck, you would lose automatically,\" says one former employee. But Zuckerberg gradually embraced news feed ads and non-social ads (i.e. ads not tied to \"likes\" and other social signals), and eventually concluded \"some decline in usage would be an acceptable trade-off for higher ad sales,\" provided the drop was more than offset by other improvements.</li>\n<li>Zuck: \"It's not like I just decided to get more involved in ads ... I needed to because basically the ad product had to be more integrated.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493501\" data-linked=\"Facebook higher following PT hike; WSJ details Zuck&#39;s transformation\" data-tweet=\"$FB - Facebook higher following PT hike; WSJ details Zuck&#39;s transformation https://seekingalpha.com/news/1493501-facebook-higher-following-pt-hike-wsj-details-zucks-transformation?source=tweet\" data-url=\"https://seekingalpha.com/news/1493501-facebook-higher-following-pt-hike-wsj-details-zucks-transformation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493481\" data-ts=\"1389034326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEZS\" target=\"_blank\">AEZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493481-aeterna-zentaris-spikes-as-fda-accepts-nda-for-filing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aeterna Zentaris spikes as FDA accepts NDA for filing</a></h4><ul>\n<li>The FDA accepts  Aeterna Zentaris' (<a href=\"https://seekingalpha.com/symbol/AEZS\" title=\"AEterna Zentaris, Inc.\">AEZS</a> <font color=\"green\">+4.1%</font>) NDA for macimorelin  acetate in AGHD for filing.</li>\n<li>The application was submitted in November.</li>\n<li>Approval would make macimorelin  acetate the \"the first  orally-administered product that induces growth hormone release to  evaluate AGHD.\"</li>\n<li>PDUFA date: November 5, 2014. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493481\" data-linked=\"Aeterna Zentaris spikes as FDA accepts NDA for filing\" data-tweet=\"$AEZS - Aeterna Zentaris spikes as FDA accepts NDA for filing https://seekingalpha.com/news/1493481-aeterna-zentaris-spikes-as-fda-accepts-nda-for-filing?source=tweet\" data-url=\"https://seekingalpha.com/news/1493481-aeterna-zentaris-spikes-as-fda-accepts-nda-for-filing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493451\" data-ts=\"1389032493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493451-yelp-rallies-following-pt-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp rallies following PT hike</a></h4><ul><li>Retail analyst <a href=\"https://twitter.com/thenotablecalls/status/420201559754960896\" target=\"_blank\">Dana Telsey</a> (head of research firm Telsey Advisory Group) has hiked her Yelp (<a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a> <font color='green'>+5.2%</font>) to a Street-high $95.</li><li>Shares of the local reviews leader have jumped above $70 in response. They're now within striking distance of their all-time high of $75.37 (set in October).</li><li>Short-covering could be contributing to today's gains. 14.6% of Yelp's float was shorted as of Dec. 13.</li></ul><div class=\"tiny-share-widget\" data-id=\"1493451\" data-linked=\"Yelp rallies following PT hike\" data-tweet=\"$YELP - Yelp rallies following PT hike https://seekingalpha.com/news/1493451-yelp-rallies-following-pt-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/1493451-yelp-rallies-following-pt-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493411\" data-ts=\"1389030996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/END\" target=\"_blank\">END</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493411-endeavour-rises-on-rochelle-update-production-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endeavour rises on Rochelle update, production guidance</a></h4><ul>     <li>Endeavour International (<a href=\"https://seekingalpha.com/symbol/END\" title=\"Endeavour International Corporation\">END</a> <font color=\"green\">+3.8%</font>) shares are higher after the E&amp;P company announced an update on the current production from the first well at the Rochelle field and the timing of the start-up of the second production well.</li>     <li>Current gross production from the first Rochelle well is 65M-70M cf/day of gas with an additional 2.5K-3K boe/day of liquids production, 6K-7K boe/day net to END's working interest in the field.</li>     <li>END also reconfirms its Q4 2013 guidance of 12K-13K boe/day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1493411\" data-linked=\"Endeavour rises on Rochelle update, production guidance\" data-tweet=\"$END - Endeavour rises on Rochelle update, production guidance https://seekingalpha.com/news/1493411-endeavour-rises-on-rochelle-update-production-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1493411-endeavour-rises-on-rochelle-update-production-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493401\" data-ts=\"1389030875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493401-sarepta-claws-back-losses-fda-letter-offers-sliver-of-hope-on-early-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta claws back losses, FDA letter offers sliver of hope on early review</a></h4><ul>\n<li>Sarepta (<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"red\">-6.1%</font>) shares are taking back some of the day's losses (<font color=\"red\">15.1%</font> at the trough after a <a href=\"https://seekingalpha.com/news/1492311-Citi-negative-on-Sarepta-Ariad-for-2014-shares-slide\" target=\"_blank\">negative view</a> issued by Citi) on <a href=\"http://www.thestreet.com/story/12211040/1/this-fda-letter-about-sarepta-and-accelerated-approval-for-eteplirsen-will-blow-your-mind.html\" target=\"_blank\">news</a> that an FDA official has sent a letter to people who have written the agency regarding the early approval of eteplirsen, noting in part, the \"FDA has reached no conclusions about the possibility of using accelerated approval for any new drug for the treatment of Duchenne muscular dystrophy, and for eteplirsen in particular.\"</li>\n<li>Adam Feuerstein opines that the consensus view on Sarepta is that the muscular dystrophy drug has virtually no chance to receive early FDA review, but that the agency \"would... might... possibly... be willing to review eteplirsen based on the existing phase II data,\" and that \"Sarepta's door isn't shut entirely.\" </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493401\" data-linked=\"Sarepta claws back losses, FDA letter offers sliver of hope on early review\" data-tweet=\"$SRPT - Sarepta claws back losses, FDA letter offers sliver of hope on early review https://seekingalpha.com/news/1493401-sarepta-claws-back-losses-fda-letter-offers-sliver-of-hope-on-early-review?source=tweet\" data-url=\"https://seekingalpha.com/news/1493401-sarepta-claws-back-losses-fda-letter-offers-sliver-of-hope-on-early-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493391\" data-ts=\"1389030358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493391-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/SEED\" title=\"Origin Agritech Limited\">SEED</a> <font color=\"green\">+31%</font>. OXBT <font color=\"green\">+30%</font>. EONC <font color=\"green\">+27%</font>. PPHM <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/FONR\" title=\"Fonar Corporation\">FONR</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/LIVE\" title=\"Live Ventures\">LIVE</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/ZN\" title=\"Zion Oil &amp; Gas Inc\">ZN</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/ALTI\" title=\"Altair Nanotechnologies Inc.\">ALTI</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/CERE\" title=\"Ceres, Inc.\">CERE</a> <font color=\"green\">+14%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/GNI\" title=\"Great Northern Iron Ore Properties\">GNI</a> <font color=\"red\">-38%</font>. <a href=\"https://seekingalpha.com/symbol/IPDN\" title=\"Professional Diversity Network\">IPDN</a> <font color=\"red\">-28%</font>. <a href=\"https://seekingalpha.com/symbol/BCOV\" title=\"Brightcove\">BCOV</a> <font color=\"red\">-21%</font>. SCSS <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/GYRO\" title=\"Gyrodyne, LLC\">GYRO</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/WH-OLD\" title=\"WSP Holdings Limited\">WH-OLD</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/CHNR\" title=\"China Natural Resources, Inc.\">CHNR</a> <font color=\"red\">-10%</font>. WPCS <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/IMI\" title=\"Intermolecular, Inc.\">IMI</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/ELMD\" title=\"Electromed, Inc.\">ELMD</a> <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1493391\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SEED $TENX $INVT - Midday Gainers / Losers https://seekingalpha.com/news/1493391-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1493391-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493351\" data-ts=\"1389029463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDXG\" target=\"_blank\">MDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493351-mimedx-slips-on-downgrade-from-northland\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MiMedx slips on downgrade from Northland</a></h4><ul>\n<li>Although \"management has done a nice job of shepherding the company through some turbulence ... at almost an $850M valuation, we believe this stock is reflecting an  overenthusiastic scenario; and at least on a fundamental basis, we  believe it is prudent to move to the sideline,\" Northland Capital's Suraj Kalia says, regarding shares of MiMedx (<a href=\"https://seekingalpha.com/symbol/MDXG\" title=\"MiMedx Group Inc.\">OTC:MDXG</a> <font color=\"red\">-7.5%</font>).</li>\n<li>MDXG has faced a number of hurdles over the past six months including questions from the FDA about the status (<a href=\"https://seekingalpha.com/news/1273272-HCT-Ps-in-focus-after-FDA-looks-at-OvaScience-MiMedx\" target=\"_blank\">HCT/P</a>) of its products and <a href=\"https://seekingalpha.com/news/1437911-New-CMS-rules-show-MiMedx-Osiris-get-pass-throughs-for-EpiFix-Grafix\" target=\"_blank\">new rules</a> regarding Medicare coverage for EpiFix. <br>\n</li>\n<li>MDXG <a href=\"http://www.streetinsider.com/Analyst+Comments/Northland+Capital+Markets+Downgrades+MiMedx+Group+%28MDXG%29+to+Market+Perform/9025235.html\" target=\"_blank\">cut to Market Perform</a> from Outperform.</li>\n<li>Price target is $6.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493351\" data-linked=\"MiMedx slips on downgrade from Northland\" data-tweet=\"$MDXG - MiMedx slips on downgrade from Northland https://seekingalpha.com/news/1493351-mimedx-slips-on-downgrade-from-northland?source=tweet\" data-url=\"https://seekingalpha.com/news/1493351-mimedx-slips-on-downgrade-from-northland\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493341\" data-ts=\"1389029221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCEI\" target=\"_blank\">BCEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493341-bonanza-creek-upped-to-buy-hess-cut-to-neutral-at-mizuho\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bonanza Creek upped to Buy, Hess cut to Neutral at Mizuho</a></h4><ul>     <li>Bonanza Creek Energy (<a href=\"https://seekingalpha.com/symbol/BCEI\" title=\"Bonanza Creek Energy\">BCEI</a> <font color=\"green\">+3.8%</font>) is <a href=\"http://www.streetinsider.com/Upgrades/Mizuho+Securities+Upgrades+Bonanza+Creek+Energy+%28BCEI%29+to+Buy/9024907.html\" target=\"_blank\">upgraded to Buy</a> from Neutral and Hess (<a href=\"https://seekingalpha.com/symbol/HES\" title=\"Hess Corporation\">HES</a> <font color=\"red\">-0.7%</font>) is cut to Neutral from Buy at Mizuho on valuation as part of the firm's broader sector outlook, which sees crude prices remaining above breakeven for key basins despite headwinds.</li>     <li>The firm expects further efficiency gains as key players in the Bakken (NYSE:<a href=\"https://seekingalpha.com/symbol/HES\" title=\"Hess Corporation\">HES</a>), Permian (<a href=\"https://seekingalpha.com/symbol/APA\" title=\"Apache Corporation\">APA</a>, <a href=\"https://seekingalpha.com/symbol/APC\" title=\"Anadarko Petroleum Corporation\">APC</a>), Eagle Ford (<a href=\"https://seekingalpha.com/symbol/MRO\" title=\"Marathon Oil Corporation\">MRO</a>, <a href=\"https://seekingalpha.com/symbol/APC\" title=\"Anadarko Petroleum Corporation\">APC</a>) and DJ Basin (<a href=\"https://seekingalpha.com/symbol/APC\" title=\"Anadarko Petroleum Corporation\">APC</a>, <a href=\"https://seekingalpha.com/symbol/NBL\" title=\"Noble Energy, Inc.\">NBL</a>, <a href=\"https://seekingalpha.com/symbol/PDCE\" title=\"PDC Energy, Inc.\">PDCE</a>, SYRG, <a href=\"https://seekingalpha.com/symbol/BCEI\" title=\"Bonanza Creek Energy\">BCEI</a>) continue to hone skills; its top picks going into 2014 are APA, Kosmos (NYSE:<a href=\"https://seekingalpha.com/symbol/KOS\" title=\"Kosmos Energy\">KOS</a>) and, on the riskier side, APC.</li>     <li>With APA, the firm sees a continued turnaround to a leaner,  shareholder-focused E&amp;P with material catalysts; with KOS, a seasoned explorer with big drilling upside alongside cash flow generation; with APC, market caution until a Tronox damages number is revealed but rebounding given solid assets and liquidity.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1493341\" data-linked=\"Bonanza Creek upped to Buy, Hess cut to Neutral at Mizuho\" data-tweet=\"$BCEI $BCEI $HES - Bonanza Creek upped to Buy, Hess cut to Neutral at Mizuho https://seekingalpha.com/news/1493341-bonanza-creek-upped-to-buy-hess-cut-to-neutral-at-mizuho?source=tweet\" data-url=\"https://seekingalpha.com/news/1493341-bonanza-creek-upped-to-buy-hess-cut-to-neutral-at-mizuho\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493301\" data-ts=\"1389028823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493301-gogo-launches-canadian-in-flight-wi-fi-network-shares-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo launches Canadian in-flight Wi-Fi network, shares higher</a></h4><ul>\n<li>Gogo (<a href=\"https://seekingalpha.com/symbol/GOGO\" title=\"Gogo\">GOGO</a> <font color=\"green\">+1.1%</font>) has flipped the switch on its Canadian air-to-ground in-flight Wi-Fi network. The company promises the network will allow it to \"offer seamless in-flight Internet service between the U.S. and Canada to its airline partners.\" (PR)</li>\n<li>Gogo also plans to offer Canadian in-flight Wi-Fi services via its Ground to Orbit (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/GTO\" title=\"Invesco Total Return Bond ETF\">GTO</a>) network, which will rely on a combo of air-to-ground and satellite systems to offer 70Mbps+ peak download speeds.</li>\n<li>Shares are trading higher. They <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1389042000000&amp;chddm=9011&amp;chls=IntervalBasedLine&amp;q=NASDAQ:GOGO&amp;ntsp=1&amp;ei=9eDKUuDrJcmCiwK2ogE\" target=\"_blank\">remain well off</a> the early-December highs (achieved with <a href=\"https://seekingalpha.com/news/1311052-Gogo-climbs-FAA-panel-recommends-allowing-WiFi-during-takeoff-landing\" target=\"_blank\">the FAA's help</a>) witnessed before Gogo's <a href=\"https://seekingalpha.com/news/1471471-Gogo-dives-as-lockup-ends-P-E-firm-distributes-shares-and-leaves-board\" target=\"_blank\">lockup expiration</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493301\" data-linked=\"Gogo launches Canadian in-flight Wi-Fi network, shares higher\" data-tweet=\"$GOGO - Gogo launches Canadian in-flight Wi-Fi network, shares higher https://seekingalpha.com/news/1493301-gogo-launches-canadian-in-flight-wi-fi-network-shares-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1493301-gogo-launches-canadian-in-flight-wi-fi-network-shares-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493291\" data-ts=\"1389028323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493291-mannkind-rallies-on-afrezza-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MannKind rallies on Afrezza optimism</a></h4><ul>\n<li>Shares of MannKind (<a href=\"https://seekingalpha.com/symbol/MNKD\" title=\"MannKind Corporation\">MNKD</a> <font color=\"green\">+5%</font>) are strong to start the week.</li>\n<li>SA contributor Maredin Capital Advisors \u2014 who has \"owned shares for the better part of six years and endured quite a bit of volatility in the process\" \u2014 likens Afrezza's market potential to Lipitor and Plavix and says FDA approval is \"<a href=\"https://seekingalpha.com/article/1929181-MannKind-Corporation-One-Large-Step-For-Shareholders-One-Gigantic-Step-For-Diabetics\" target=\"_blank\">a low hurdle at this juncture</a>.\"</li>\n<li>The author goes on to say that Afrezza \"will likely become the dominant player in the $44B insulin market due to its unique pharmacokinetics/efficacy and convenience.\" The article appeared elsewhere last month.</li>\n<li>Also bullish is SA contributor Stock Whisper, who <a href=\"https://seekingalpha.com/article/1882301-More-Catalysts-For-MannKind\" target=\"_blank\">highlights</a> the company's <a href=\"http://www.media-server.com/m/p/5exdi3ac\" target=\"_blank\">presentation</a> at the Piper Jaffray healthcare conference.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493291\" data-linked=\"MannKind rallies on Afrezza optimism\" data-tweet=\"$MNKD - MannKind rallies on Afrezza optimism https://seekingalpha.com/news/1493291-mannkind-rallies-on-afrezza-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/1493291-mannkind-rallies-on-afrezza-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493251\" data-ts=\"1389027265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEOS\" target=\"_blank\">GEOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493251-geospace-technologies-cut-to-sell-at-bws-financial-shares-minus-5_8-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Geospace Technologies cut to Sell at BWS Financial, shares -5.8%</a></h4><ul>     <li>Geospace Technologies (<a href=\"https://seekingalpha.com/symbol/GEOS\" title=\"Geospace Technologies Corporation\">GEOS</a> <font color=\"red\">-5.8%</font>) is <a href=\"http://www.streetinsider.com/Downgrades/BWS+Financial+Downgrades+Geospace+Technologies+%28GEOS%29+to+Sell/9025812.html\" target=\"_blank\">downgraded to Sell</a> from Hold at BWS Financial.</li>\n<li>GEOS' growth in the past year mostly has been the result of a one-time contract from Statoil, which will be fulfilled in H1 2014; the firm worries that the timing of the STO contract, a shrinking U.S. capex budget, a slow Canadian winter, a competitive pricing environment, and no timing as to a recovery in the U.S. exploration market could lead to a disappointing 2014.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1493251\" data-linked=\"Geospace Technologies cut to Sell at BWS Financial, shares -5.8%\" data-tweet=\"$GEOS - Geospace Technologies cut to Sell at BWS Financial, shares -5.8% https://seekingalpha.com/news/1493251-geospace-technologies-cut-to-sell-at-bws-financial-shares-minus-5_8-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1493251-geospace-technologies-cut-to-sell-at-bws-financial-shares-minus-5_8-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493221\" data-ts=\"1389026982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHX\" target=\"_blank\">ATHX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493221-athersys-rises-article-projects-big-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Athersys rises, article projects big upside</a></h4><ul>\n<li>Shares of Athersys (<a href=\"https://seekingalpha.com/symbol/ATHX\" title=\"Athersys, Inc.\">ATHX</a> <font color=\"green\">+6.6%</font>) are trading notably higher on heavy volume.</li>\n<li>Perhaps helping to tip sentiment is SA contributor U.S. Biotech Investor, who highlights results from preclinical studies of MultiStem and says \"investors are <a href=\"https://seekingalpha.com/article/1928461-Athersys-Remarkable-Treatment-For-Ischemic-Stroke-Feasibly-On-The-Way\" target=\"_blank\">beginning to recognize and appreciate</a> the potential value of the [company's] portfolio.\"</li>\n<li>The author (who <a href=\"https://seekingalpha.com/instablog/15280302-U-S-Biotech-Investor/2403762-A-Comprehensive-Look-At-Athersys\" target=\"_blank\">penned a bullish post</a> on the shares back in November) says reforms in Japanese pharmaceutical legislation and new information gleaned from Piper Jaffray's healthcare conference have created even more upside for the stock, which, according to the article, could go to $15.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493221\" data-linked=\"Athersys rises, article projects big upside\" data-tweet=\"$ATHX - Athersys rises, article projects big upside https://seekingalpha.com/news/1493221-athersys-rises-article-projects-big-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/1493221-athersys-rises-article-projects-big-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493121\" data-ts=\"1389024895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLOG\" target=\"_blank\">TLOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493121-needham-starts-tetralogic-pharma-at-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham starts TetraLogic Pharma at Buy</a></h4><ul>\n<li>Recently public TetraLogic Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/TLOG\" title=\"TetraLogic Pharmaceuticals Corporation\">OTC:TLOG</a> <font color=\"green\">+4%</font>) trades higher in early action.<br>\n</li>\n<li>Helping the cause is Needham's Chad Messer, who has <a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Starts+Tetralogic+Pharmaceuticals+%28TLOG%29+at+Buy/9024811.html\" target=\"_blank\">initiated the shares</a> at Buy with a $16 price target.</li>\n<li>TLOG \"is now developing birinapant as a best-in-class IAP inhibitor with a  well established safety profile in multiple indications for cancer and  infectious disease,\" Messer notes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493121\" data-linked=\"Needham starts TetraLogic Pharma at Buy\" data-tweet=\"$TLOG - Needham starts TetraLogic Pharma at Buy https://seekingalpha.com/news/1493121-needham-starts-tetralogic-pharma-at-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/1493121-needham-starts-tetralogic-pharma-at-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493081\" data-ts=\"1389024427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEF\" target=\"_blank\">TEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493081-telefonica-denies-tim-acquisition-breakup-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telefonica denies TIM acquisition/breakup report</a></h4><ul>\n<li>Telefonica (<a href=\"https://seekingalpha.com/symbol/TEF\" title=\"Telefonica S.A.\">TEF</a> <font color=\"green\">+0.2%</font>) <a href=\"http://www.reuters.com/article/2014/01/06/us-telefonica-brazil-idUSBREA050A220140106?feedType=RSS&amp;feedName=technologyNews\" target=\"_blank\">denies</a> an Italian media <a href=\"https://seekingalpha.com/news/1489901-Telefonica-eyes-takover-of-TIs-Brazilian-unit\" target=\"_blank\">report</a> stating the carrier and Brazilian subsidiary Vivo (<a href=\"https://seekingalpha.com/symbol/VIV\" title=\"Telefonica Brasil, S.A\">VIV</a> <font color=\"red\">-0.7%</font>) are working with rivals America Movil (<a href=\"https://seekingalpha.com/symbol/AMX\" title=\"America Movil SA de CV\">AMX</a> <font color=\"green\">+0.4%</font>) and Oi (OIBR <font color=\"red\">-1.7%</font>) to acquire and break up Telecom Italia's (<a href=\"https://seekingalpha.com/symbol/TI\" title=\"Telecom Italia S.P.A.\">TI</a> <font color=\"green\">+0.1%</font>) Brazilian unit, TIM Participacoes (<a href=\"https://seekingalpha.com/symbol/TSU\" title=\"TIM Participações S.A.\">TSU</a> <font color=\"red\">-1%</font>). TIM and Oi are trading moderately lower today after <a href=\"https://seekingalpha.com/news/1490491-Report-Telefonica-Oi-and-Claro-aim-to-take-over-TIM\" target=\"_blank\">flying higher</a> on Friday in response to the report.</li>\n<li>Telefonica adds it hasn't talked with Brazil's antitrust regulator Cade about a deal. Reuters <a href=\"https://seekingalpha.com/news/1472051-Brazil-reportedly-gives-Telefonica-18-months-to-lower-presence\" target=\"_blank\">recently reported</a> Cade has given Telefonica, which owns a large indirect stake in Telecom Italia, 18 months to lower its Brazilian market presence, either by cutting ties with TIM or finding a partner for Vivo.</li>\n<li>However, Cade reportedly prefers TIM to be <a href=\"https://seekingalpha.com/news/1298892-Telecom-Italia-resists-pressure-to-sell-Latin-ops-shares-fall\" target=\"_blank\">sold in whole</a> to a new market participant, rather than piecemeal to rivals. Telefonica, America Movil, and Oi would likely prefer that didn't happen, since it could spell competition from a major foreign carrier such as AT&amp;T or Vodafone.</li>\n<li>Telefonica and <a href=\"https://seekingalpha.com/news/1465371-BlackRock-increases-stake-in-TI-ahead-of-shareholder-vote\" target=\"_blank\">others</a> have been pressuring Telecom Italia to explore a sale of TIM, but the debt-laden Italian telco <a href=\"https://seekingalpha.com/news/1349192-TIM-CEO-wants-Telefonica-to-keep-out-of-Telecom-Italias-Brazilian-ops\" target=\"_blank\">has been reluctant</a> to cut its ties with a major growth market.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493081\" data-linked=\"Telefonica denies TIM acquisition/breakup report\" data-tweet=\"$TEF $TEF $VIV - Telefonica denies TIM acquisition/breakup report https://seekingalpha.com/news/1493081-telefonica-denies-tim-acquisition-breakup-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1493081-telefonica-denies-tim-acquisition-breakup-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1493011\" data-ts=\"1389022039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTX\" target=\"_blank\">PTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1493011-cantor-turns-bearish-on-pernix-after-lawsuit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cantor turns bearish on Pernix after lawsuit</a></h4><ul>\n<li>Cantor <a href=\"http://www.streetinsider.com/Analyst+Comments/Cantor+Fitzgerald+Downgrades+Pernix+Therapeutics+%28PTX%29+to+Sell/9025254.html\" target=\"_blank\">cuts</a> Pernix Therapeutics (<a href=\"https://seekingalpha.com/symbol/PTX\" title=\"Pernix Therapeutics Holdings, Inc.\">PTX</a> <font color=\"red\">-4.6%</font>) to Sell from Hold.</li>\n<li>\"On December 18, PTX was sued for breach of contract, specific  performance, and attorney's fees in the U.S. District Court of the  Southern District of Texas by a group of Cypress shareholders,\" analyst Irina Rivkind notes, adding that she anticipates either \"a negative reaction in the stock or potential dilution to shareholders from an equity financing event.\"</li>\n<li>$2 target maintained, as Rivkind still thinks the company has enough assets to warrant a takeout in that price range.</li>\n<li>For more on Rivkind's takeout scenario, see <a href=\"https://seekingalpha.com/news/1409432-Cantor-upgrades-Pernix-Therapeutics-thinks-company-may-be-forced-into-sale\" target=\"_blank\">here</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1493011\" data-linked=\"Cantor turns bearish on Pernix after lawsuit\" data-tweet=\"$PTX $PTX-OLD - Cantor turns bearish on Pernix after lawsuit https://seekingalpha.com/news/1493011-cantor-turns-bearish-on-pernix-after-lawsuit?source=tweet\" data-url=\"https://seekingalpha.com/news/1493011-cantor-turns-bearish-on-pernix-after-lawsuit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492981\" data-ts=\"1389021867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492981-ism-services-new-orders-contract-first-time-sine-july-2009\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ISM Services: New Orders contract first time sine July 2009</a></h4><ul>\n<li>Treasury prices get a boost after the <a href=\"https://seekingalpha.com/news/1492871\" target=\"_blank\">slow ISM services report</a> - the headline of 53 missed consensus expectations of 54.8, but New Orders tumbled 7 points into contraction territory of 49.4 after 52 consecutive months above 50.</li>\n<li>\"Early, severe winter weather has had a major impact on business. Both customers and employees were unable to reach the workplace,\" says one commenter from the Arts, Entertainment, and Recreation industry.</li>\n<li>The 10-year yield is down 4 basis points at 2.96%. <a href=\"https://seekingalpha.com/symbol/tlt\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"green\">+0.5%</font>, <a href=\"https://seekingalpha.com/symbol/tbt\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a> <font color=\"red\">-1.1%</font>.</li>\n<li>Related ETFs: <a href=\"https://seekingalpha.com/symbol/tbt\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a>, <a href=\"https://seekingalpha.com/symbol/tlt\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a>, <a href=\"https://seekingalpha.com/symbol/tmv\" title=\"Direxion Daily 30-Year Treasury Bear 3x Shares ETF\">TMV</a>, <a href=\"https://seekingalpha.com/symbol/tbf\" title=\"ProShares Short 20+ Year Treasury ETF\">TBF</a>, <a href=\"https://seekingalpha.com/symbol/edv\" title=\"Vanguard Extended Duration Treasury ETF\">EDV</a>, <a href=\"https://seekingalpha.com/symbol/ttt\" title=\"ProShares UltraPro Short 20+ Year Treasury ETF\">TTT</a>, <a href=\"https://seekingalpha.com/symbol/tmf\" title=\"Direxion Daily 30-Year Treasury Bull 3x Shares ETF\">TMF</a>, <a href=\"https://seekingalpha.com/symbol/tlh\" title=\"iShares 10-20 Year Treasury Bond ETF\">TLH</a>, <a href=\"https://seekingalpha.com/symbol/zroz\" title=\"PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF\">ZROZ</a>, <a href=\"https://seekingalpha.com/symbol/sbnd\" title=\"PowerShares DB 3x Short 25+ Year Treasury Bond ETN\">SBND</a>, <a href=\"https://seekingalpha.com/symbol/dlbs\" title=\"iPath U.S. Treasury Long Bond Bear ETN\">DLBS</a>, <a href=\"https://seekingalpha.com/symbol/vglt\" title=\"Vanguard Long-Term Government Bond Index ETF\">VGLT</a>, <a href=\"https://seekingalpha.com/symbol/ubt\" title=\"ProShares Ultra 20+ Year Treasury ETF\">UBT</a>, <a href=\"https://seekingalpha.com/symbol/tlo\" title=\"SPDR Barclays Long Term Treasury ETF\">TLO</a>, <a href=\"https://seekingalpha.com/symbol/lbnd\" title=\"PowerShares DB 3x Long 25+ Year Treasury Bond ETN\">LBND</a>, <a href=\"https://seekingalpha.com/symbol/tybs\" title=\"Direxion Daily 20+ Year Treasury Bear 1x ETF\">TYBS</a>, <a href=\"https://seekingalpha.com/symbol/tenz\" title=\"PIMCO 7-15 Year U.S. Treasury Index ETF\">TENZ</a>, <a href=\"https://seekingalpha.com/symbol/dlbl\" title=\"iPath U.S. Treasury Long Bond Bull ETN\">DLBL</a>\n</li>\n<li><a href=\"http://www.ism.ws/ISMReport/NonMfgROB.cfm?navItemNumber=12943\" target=\"_blank\">Full ISM report</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492981\" data-linked=\"ISM Services: New Orders contract first time sine July 2009\" data-tweet=\"$TLT $TBT $TMV - ISM Services: New Orders contract first time sine July 2009 https://seekingalpha.com/news/1492981-ism-services-new-orders-contract-first-time-sine-july-2009?source=tweet\" data-url=\"https://seekingalpha.com/news/1492981-ism-services-new-orders-contract-first-time-sine-july-2009\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492961\" data-ts=\"1389021762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KL\" target=\"_blank\">KL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492961-kirkland-lake-minus-9_6-percent-as-it-starts-strategic-review-process\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kirkland Lake -9.6% as it starts strategic review process</a></h4><ul>     <li>Kirkland Lake Gold (KGILF <font color=\"red\">-9.6%</font>) says it has <a href=\"http://finance.yahoo.com/news/kirkland-lake-gold-announces-strategic-070000875.html\" target=\"_blank\">started a strategic review process</a> and is considering the sales of assets or shares, hoping to create value for shareholders after its share price tumbled in 2013.</li>     <li>The gold producer also says Brian Hinchcliffe has resigned as deputy chairman and as a board member but will consult on the strategic review process.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1492961\" data-linked=\"Kirkland Lake -9.6% as it starts strategic review process\" data-tweet=\"$KL - Kirkland Lake -9.6% as it starts strategic review process https://seekingalpha.com/news/1492961-kirkland-lake-minus-9_6-percent-as-it-starts-strategic-review-process?source=tweet\" data-url=\"https://seekingalpha.com/news/1492961-kirkland-lake-minus-9_6-percent-as-it-starts-strategic-review-process\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492951\" data-ts=\"1389021272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492951-grocery-store-stocks-off-to-sluggish-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery store stocks off to sluggish start</a></h4><ul> <li>Shares of Whole Foods Market (WFM <font color=\"red\">-4%</font>) are down sharply in early trading as grocery stocks start the week off poorly.</li> <li>The move appears related in part to worries of lower store traffic and higher logistical costs for grocery store operators due to the recent winter storms in the U.S.</li> <li>Decliners: <a href=\"https://seekingalpha.com/symbol/RNDY\" title=\"Roundy's Supermarkets, Inc\">RNDY</a> <font color=\"red\">-2.4%</font>, <a href=\"https://seekingalpha.com/symbol/VLGEA\" title=\"Village Super Market, Inc.\">VLGEA</a> <font color=\"red\">-1.4%</font>, <a href=\"https://seekingalpha.com/symbol/SFM\" title=\"Sprouts Farmers Market\">SFM</a> <font color=\"red\">-1.1%</font>, <a href=\"https://seekingalpha.com/symbol/SWY\" title=\"Safeway Inc.\">SWY</a> <font color=\"red\">-0.7%</font>, <a href=\"https://seekingalpha.com/symbol/FWM\" title=\"Fairway Group Holdings Corp.\">FWM</a> <font color=\"red\">-2.5%</font>, <a href=\"https://seekingalpha.com/symbol/KR\" title=\"Kroger Co.\">KR</a> <font color=\"red\">-0.4%</font>, <a href=\"https://seekingalpha.com/symbol/SVU\" title=\"SUPERVALU Inc.\">SVU</a> <font color=\"red\">-4.2%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1492951\" data-linked=\"Grocery store stocks off to sluggish start\" data-tweet=\"$AMZN $AMZN $RNDY - Grocery store stocks off to sluggish start https://seekingalpha.com/news/1492951-grocery-store-stocks-off-to-sluggish-start?source=tweet\" data-url=\"https://seekingalpha.com/news/1492951-grocery-store-stocks-off-to-sluggish-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492941\" data-ts=\"1389020946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WAVX\" target=\"_blank\">WAVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492941-wave-systems-spikes-on-samsung-collaboration-announcement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wave Systems spikes on Samsung collaboration announcement</a></h4><ul><li>Shares of Wave Systems (<a href='https://seekingalpha.com/symbol/WAVX' title='Wave Systems Corp.'>WAVX</a> <font color='green'>+24.9%</font>) spike after Samsung <a href=\"http://www.businesswire.com/news/home/20140106006074/en/Samsung-Announces-840-EVO-SSD-Enhanced-Security\" target=\"_blank\">announces </a>a&nbsp;SSD Self-Encrypting Drive security solution for the 840 EVO SSD, which was \"enabled through collaboration with Wave System's Wave Cloud and EMBASSY Remote Administration Server.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"1492941\" data-linked=\"Wave Systems spikes on Samsung collaboration announcement\" data-tweet=\"$WAVX - Wave Systems spikes on Samsung collaboration announcement https://seekingalpha.com/news/1492941-wave-systems-spikes-on-samsung-collaboration-announcement?source=tweet\" data-url=\"https://seekingalpha.com/news/1492941-wave-systems-spikes-on-samsung-collaboration-announcement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492901\" data-ts=\"1389020531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOL\" target=\"_blank\">SOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492901-renesola-lands-420mw-japanese-deal-shares-jump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReneSola lands 420MW Japanese deal, shares jump</a></h4><ul>\n<li>ReneSola (<a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"green\">+7.1%</font>) has scored a contract to supply 420MW of solar panels to an unnamed Japanese solar project developer for use in ten power plants to be installed in Japan's mountainous regions.  (PR)</li>\n<li>Delivery begins this month, but isn't expected to be finished until December 2015.</li>\n<li>The fast-growing/high-margin Japanese market has been a boon for many Chinese solar module vendors. A trade group <a href=\"https://seekingalpha.com/news/1451351-Solar-stocks-fall-in-spite-of-market-rally-ReneSola-leads-the-way\" target=\"_blank\">estimated</a> Japanese solar cell/module imports rose 30% Q/Q and 540% Y/Y in Q3, and accounted for 58% of local shipments.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492901\" data-linked=\"ReneSola lands 420MW Japanese deal, shares jump\" data-tweet=\"$SOL - ReneSola lands 420MW Japanese deal, shares jump https://seekingalpha.com/news/1492901-renesola-lands-420mw-japanese-deal-shares-jump?source=tweet\" data-url=\"https://seekingalpha.com/news/1492901-renesola-lands-420mw-japanese-deal-shares-jump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492851\" data-ts=\"1389020168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPX\" target=\"_blank\">TPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492851-furniture-and-bedding-stocks-turn-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Furniture and bedding stocks turn lower</a></h4><ul> <li>A dire <a href=\"https://seekingalpha.com/news/1492831-Select-Comfort-craters-following-sales-warning\" target=\"_blank\">outlook</a> from Select Comfort on sales and profit for 2014 is taking a toll on other related retailers.</li> <li>Decliners: <a href=\"https://seekingalpha.com/symbol/TPX\" title=\"Tempur Sealy International Inc.\">TPX</a> <font color=\"red\">-4.8%</font>, <a href=\"https://seekingalpha.com/symbol/ETH\" title=\"Ethan Allen Interiors Inc.\">ETH</a> <font color=\"red\">-2.2%</font>, <a href=\"https://seekingalpha.com/symbol/LZB\" title=\"La-Z-Boy Incorporated\">LZB</a> <font color=\"red\">-1.0%</font>, <a href=\"https://seekingalpha.com/symbol/MFRM\" title=\"Mattress Firm Holding Corp.\">MFRM</a> <font color=\"red\">-4.8%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1492851\" data-linked=\"Furniture and bedding stocks turn lower\" data-tweet=\"$TPX $TPX $ETH - Furniture and bedding stocks turn lower https://seekingalpha.com/news/1492851-furniture-and-bedding-stocks-turn-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/1492851-furniture-and-bedding-stocks-turn-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492841\" data-ts=\"1389020040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HBAN\" target=\"_blank\">HBAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492841-huntington-no-longer-a-sell-at-barclays\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huntington no longer a sell at Barclays</a></h4><ul><li>Barclays throws in the towel on its Sell rating on Huntington Bancshares (<a href=\"https://seekingalpha.com/symbol/HBAN\" title=\"Huntington Bancshares Incorporated\">HBAN</a> <font color=\"green\">+1%</font>), upgrading <a href=\"http://www.streetinsider.com/Analyst+PT+Change/Barclays+Upgrades+Huntington+Bancshares+%28HBAN%29+to+Equalweight/9024633.html\" target=\"_blank\">to Hold</a> with price target raised to $10 from $9. The stock gained about 45% over the past year.</li></ul><div class=\"tiny-share-widget\" data-id=\"1492841\" data-linked=\"Huntington no longer a sell at Barclays\" data-tweet=\"$HBAN - Huntington no longer a sell at Barclays https://seekingalpha.com/news/1492841-huntington-no-longer-a-sell-at-barclays?source=tweet\" data-url=\"https://seekingalpha.com/news/1492841-huntington-no-longer-a-sell-at-barclays\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492831\" data-ts=\"1389019837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNBR\" target=\"_blank\">SNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492831-select-comfort-craters-following-sales-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select Comfort craters following sales warning</a></h4><ul> <li>Select Comfort (SCSS <font color=\"red\">-18.1%</font>) says Q4 sales came in at $231M on flat comparable store sales growth. Analysts forecast $242M in sales for the period.</li> <li>The company warns that EPS will fall below estimates due to weak demand the retailer saw following Cyber Monday. Perhaps even more alarming, the \"challenging\" environment is expected to persevere in 2014, according to CEO Shelly Ibach.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1492831\" data-linked=\"Select Comfort craters following sales warning\" data-tweet=\"$SNBR - Select Comfort craters following sales warning https://seekingalpha.com/news/1492831-select-comfort-craters-following-sales-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/1492831-select-comfort-craters-following-sales-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492821\" data-ts=\"1389019801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPST\" target=\"_blank\">CPST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492821-capstone-announces-additional-24-mw-in-russian-orders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capstone announces additional 24 MW in Russian orders</a></h4><ul>     <li>Capstone Turbine (<a href=\"https://seekingalpha.com/symbol/CPST\" title=\"Capstone Turbine Corporation\">CPST</a> <font color=\"green\">+1.7%</font>) says it recently received two orders totaling 24 mw from its Russian distribution partner for new associated gas and pipeline projects.</li>     <li>CPST says its low-emission microturbines will be installed at modular power stations, with several to be fueled by untreated associated gas from well sites that otherwise would be flared; recent estimates put the amount of flared or wasted associated gas in Russia at ~40B cm/year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1492821\" data-linked=\"Capstone announces additional 24 MW in Russian orders\" data-tweet=\"$CPST - Capstone announces additional 24 MW in Russian orders https://seekingalpha.com/news/1492821-capstone-announces-additional-24-mw-in-russian-orders?source=tweet\" data-url=\"https://seekingalpha.com/news/1492821-capstone-announces-additional-24-mw-in-russian-orders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492801\" data-ts=\"1389019569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492801-tech-ratings-change-roundup-first-solar-solarcity-ebay-riverbed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech ratings change roundup: First Solar, SolarCity, eBay, Riverbed</a></h4><ul><li>First Solar (<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color='red'>-6.3%</font>) has been cut to Sell by Goldman, and SolarCity (SCTY <font color='green'>+11.2%</font>) has been upgraded to Conviction Buy.</li><li>eBay (<a href='https://seekingalpha.com/symbol/EBAY' title='eBay Inc.'>EBAY</a> <font color='red'>-2.7%</font>) has been cut to Equal Weight by Morgan Stanley.</li><li>Riverbed (<a href='https://seekingalpha.com/symbol/RVBD' title='Riverbed Technology, Inc.'>RVBD</a> <font color='red'>-0.6%</font>) has been cut to Hold from Strong Buy by Needham.</li><li>JinkoSolar (<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='green'>+7.6%</font>) and Trina (<a href='https://seekingalpha.com/symbol/TSL' title='Trina Solar Limited'>TSL</a> <font color='green'>+5.9%</font>) have been started at Buy by Jefferies</li><li>SolarWinds (<a href='https://seekingalpha.com/symbol/SWI' title='SolarWinds, Inc.'>SWI</a> <font color='green'>+1.7%</font>) has been upgraded to Overweight by Evercore.</li><li>Manhattan Associates (<a href='https://seekingalpha.com/symbol/MANH' title='Manhattan Associates, Inc.'>MANH</a> <font color='green'>+3.2%</font>) has been upgraded to Outperform by Raymond James.</li><li>UMC (<a href='https://seekingalpha.com/symbol/UMC' title='United Microelectronics Corporation'>UMC</a> <font color='green'>+0.5%</font>) has been upgraded to Overweight by UBS.</li><li>Ingram Micro (<a href='https://seekingalpha.com/symbol/IM' title='Ingram Micro Inc.'>IM</a> <font color='green'>+0.6%</font>) has been upgraded to Overweight by Barclays.</li><li>Dupont Fabros (<a href='https://seekingalpha.com/symbol/DFT' title='DuPont Fabros Technology'>DFT</a> <font color='green'>+0.9%</font>) has been upgraded to Outperform by Baird.</li><li>Rambus (<a href='https://seekingalpha.com/symbol/RMBS' title='Rambus, Inc.'>RMBS</a> <font color='red'>-3.6%</font>) has been cut to Hold by Jefferies.</li><li>Arris (<a href='https://seekingalpha.com/symbol/ARRS' title='ARRIS International plc'>ARRS</a> <font color='red'>-2.5%</font>) has been cut to Equal Weight by Barclays.</li><li>Geospace Technologies (<a href='https://seekingalpha.com/symbol/GEOS' title='Geospace Technologies Corporation'>GEOS</a> <font color='red'>-4%</font>) has been cut to Sell by BWS Financial.</li><li>Trimble (<a href='https://seekingalpha.com/symbol/TRMB' title='Trimble, Inc.'>TRMB</a> <font color='red'>-2.1%</font>) has been cut to Hold by Craig-Hallum.</li><li>Autohome (<a href='https://seekingalpha.com/symbol/ATHM' title='Autohome Inc.'>ATHM</a> <font color='red'>-9.6%</font>) has been started at Neutral by Deutsche and Piper, and at Sell by Goldman, on underwriter coverage day.</li></ul><div class=\"tiny-share-widget\" data-id=\"1492801\" data-linked=\"Tech ratings change roundup: First Solar, SolarCity, eBay, Riverbed\" data-tweet=\"$FSLR $FSLR $TSLA - Tech ratings change roundup: First Solar, SolarCity, eBay, Riverbed https://seekingalpha.com/news/1492801-tech-ratings-change-roundup-first-solar-solarcity-ebay-riverbed?source=tweet\" data-url=\"https://seekingalpha.com/news/1492801-tech-ratings-change-roundup-first-solar-solarcity-ebay-riverbed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492771\" data-ts=\"1389019461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLRN\" target=\"_blank\">XLRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492771-citi-lifts-target-on-acceleron-pharma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi lifts target on Acceleron Pharma</a></h4><ul>\n<li>Citi <a href=\"http://www.streetinsider.com/Analyst+Comments/Acceleron+Pharma+%28XLRN%29+Target+Lifted+to+%2450+at+Citi+on+Potential+Blockbuster+Anemia+Drugs/9025781.html\" target=\"_blank\">sees good things ahead</a> for Acceleron Pharma (<a href=\"https://seekingalpha.com/symbol/XLRN\" title=\"Acceleron Pharma Inc.\">XLRN</a> <font color=\"green\">+2.4%</font>) in 2014, as analyst Yaron Werber reiterates a Buy rating.</li>\n<li>\"In 2014 we expect multiple catalysts, extensive partnership with Celgene, and clinical data to continue to drive interest,\" Werber says, adding that Citi sees \"data in both MDS and thalassemia [being] released at ASCO and EHA in June.\"</li>\n<li>Price target hiked to $50 from $30.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492771\" data-linked=\"Citi lifts target on Acceleron Pharma\" data-tweet=\"$XLRN - Citi lifts target on Acceleron Pharma https://seekingalpha.com/news/1492771-citi-lifts-target-on-acceleron-pharma?source=tweet\" data-url=\"https://seekingalpha.com/news/1492771-citi-lifts-target-on-acceleron-pharma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492731\" data-ts=\"1389019232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492731-pluristem-to-present-plx-pad-cell-data-later-this-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pluristem to present PLX-PAD cell data later this month</a></h4><ul>\n<li>Pluristem Therapeutics (<a href=\"https://seekingalpha.com/symbol/PSTI\" title=\"Pluristem Therapeutics, Inc.\">PSTI</a> <font color=\"green\">+4.7%</font>) gets an early lift from an announcement that the company will present results of a Phase 1/2 clinical trial of PLX-PAD cells for the treatment of muscle injury on January 21.</li>\n<li>\"Data from this clinical trial will give us information regarding other  potential surgical orthopedic injuries and non-surgical sports related  injuries for which our PLX-PAD cells may be beneficial,\" CEO Zami Aberman says. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492731\" data-linked=\"Pluristem to present PLX-PAD cell data later this month\" data-tweet=\"$PSTI - Pluristem to present PLX-PAD cell data later this month https://seekingalpha.com/news/1492731-pluristem-to-present-plx-pad-cell-data-later-this-month?source=tweet\" data-url=\"https://seekingalpha.com/news/1492731-pluristem-to-present-plx-pad-cell-data-later-this-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492721\" data-ts=\"1389019224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HGG\" target=\"_blank\">HGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492721-hhgregg-lower-after-sales-report-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">hhgregg lower after sales report disappoints</a></h4><ul> <li>hhgregg (<a href=\"https://seekingalpha.com/symbol/HGG\" title=\"hhgregg, Inc.\">HGG</a> <font color=\"red\">-8.2%</font>) estimates net sales rose 7.6% in FQ3 to $799.6M.</li> <li>Comparable store sales fell 11.2% during the period despite some gains with appliance sales.</li> <li>The revenue mark is well-below analyst estimates.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1492721\" data-linked=\"hhgregg lower after sales report disappoints\" data-tweet=\"$HGG - hhgregg lower after sales report disappoints https://seekingalpha.com/news/1492721-hhgregg-lower-after-sales-report-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/1492721-hhgregg-lower-after-sales-report-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492671\" data-ts=\"1389018356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTR\" target=\"_blank\">DLTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492671-johnson-rice-sees-upside-for-dollar-tree\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Johnson Rice sees upside for Dollar Tree</a></h4><ul> <li>Boutique firm Johnson Rice <a href=\"http://www.streetinsider.com/Upgrades/Johnson+Rice+Upgrades+Dollar+Tree+%28DLTR%29+to+Overweight/9025810.html\" target=\"_blank\">upgrades</a> Dollar Tree (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DLTR\" title=\"Dollar Tree, Inc.\">DLTR</a>) to an Overweight rating from Equalweight.</li> <li>The company has received high marks from retail watchers for its holiday season strategy and assortment.</li> <li>DLTR <font color=\"green\">+0.8%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1492671\" data-linked=\"Johnson Rice sees upside for Dollar Tree\" data-tweet=\"$DLTR - Johnson Rice sees upside for Dollar Tree https://seekingalpha.com/news/1492671-johnson-rice-sees-upside-for-dollar-tree?source=tweet\" data-url=\"https://seekingalpha.com/news/1492671-johnson-rice-sees-upside-for-dollar-tree\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492651\" data-ts=\"1389018329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492651-pandora-announces-strong-metrics-auto-ad-platform-shares-plus-5_7-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora announces strong metrics, auto ad platform; shares +5.7% premarket</a></h4><ul>\n<li>Pandora's (NYSE:<a href=\"https://seekingalpha.com/symbol/P\" title=\"Pandora Media\">P</a>) December audience metrics suggest the Web/mobile radio leader continues to successfully head off iTunes Radio's challenge. Listener hours totaled 1.58B, +6% M/M (aided by an extra day) and +13% Y/Y.</li>\n<li>Pandora's share of U.S. radio listening totaled 8.60%, up from <a href=\"https://seekingalpha.com/news/1444861-Pandora-higher-after-gaining-listeners-and-market-share-in-Nov\" target=\"_blank\">8.44% in November</a>, <a href=\"https://seekingalpha.com/news/1386182-Pandora-higher-after-releasing-Oct-metrics-engagement-rises-listeners-drop\" target=\"_blank\">8.06% in October</a>, and 7.58% a year ago. Active listeners, pressured for a short while by iTunes Radio, rose 5% M/M and 13% Y/Y to 76.2M.</li>\n<li>Also: Pandora is using the first day of CES to announce it will launch an in-car ad platform this month.  The platform will support 15- and 30-second ad spots that will run via the 130 vehicles and 270 aftermarket products featuring Pandora integration. Initial advertisers include BP, Ford, State Farm, and Taco Bell.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/1407692-New-highs-for-Pandora-after-Needham-lifts-estimates\" target=\"_blank\">Needham</a> recently highlighted auto monetization as a major untapped growth opportunity for Pandora, while asserting the company has a 5-year lead on automotive rivals. The company's big 2013 <a href=\"https://seekingalpha.com/news/1426961-Pandoras-mobile-monetization-keeps-improving-sales-spending-takes-a-toll\" target=\"_blank\">sales investments</a> (particularly for local ad sales) could help its cause.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492651\" data-linked=\"Pandora announces strong metrics, auto ad platform; shares +5.7% premarket\" data-tweet=\"$P - Pandora announces strong metrics, auto ad platform; shares +5.7% premarket https://seekingalpha.com/news/1492651-pandora-announces-strong-metrics-auto-ad-platform-shares-plus-5_7-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1492651-pandora-announces-strong-metrics-auto-ad-platform-shares-plus-5_7-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492641\" data-ts=\"1389018249\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEED\" target=\"_blank\">SEED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492641-origin-agritech-plus-27_8-percent-pre-market-investors-salivate-before-fq4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Origin Agritech +27.8% pre-market, investors salivate before FQ4 results</a></h4><ul>\n<li>Shares of Origin Agritech (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SEED\" title=\"Origin Agritech Limited\">SEED</a>) <font color=\"green\">jump 27.8%</font> pre-market, adding to a <font color=\"green\">44.9% gain </font>on Friday, as investors anticipate mouthwatering FQ4 results on Jan. 8.</li>\n<li>Making investors salivate: the company disclosed that it had deferred revenue (crop seeds after sales arrangements are made, delivery is made, or pre-payment is received but before the final sales price is fixed) of RMB338.4M ($54.8M) as of June 30 vs RMB257.3M on June 30, 2012. Origin added that it expects \"the majority of deferred revenues will be recorded on the income statement in the fiscal fourth quarter of 2013.\" (<a href=\"http://www.sec.gov/Archives/edgar/data/1321851/000114420413043340/v352071_ex99-1.htm\" target=\"_blank\">6-K</a>)</li>\n<li>Agria (NYSE:<a href=\"https://seekingalpha.com/symbol/GRO\" title=\"Agria Corporation\">GRO</a>) shares are following in sympathy, <font color=\"green\">+9.6%</font> pre-market.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492641\" data-linked=\"Origin Agritech +27.8% pre-market, investors salivate before FQ4 results\" data-tweet=\"$SEED $SEED $GRO - Origin Agritech +27.8% pre-market, investors salivate before FQ4 results https://seekingalpha.com/news/1492641-origin-agritech-plus-27_8-percent-pre-market-investors-salivate-before-fq4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1492641-origin-agritech-plus-27_8-percent-pre-market-investors-salivate-before-fq4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492621\" data-ts=\"1389017975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492621-fedex-plus-1_9-percent-on-buyback-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx +1.9% on buyback news</a></h4><ul> <li>FedEx (NYSE:<a href=\"https://seekingalpha.com/symbol/FDX\" title=\"FedEx Corporation\">FDX</a>) plans to offer $2B in new notes and accelerate its buyback program.</li> <li>PR</li> <li>FDX <font color=\"green\">+1.9%</font> premarket</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1492621\" data-linked=\"FedEx +1.9% on buyback news\" data-tweet=\"$FDX - FedEx +1.9% on buyback news https://seekingalpha.com/news/1492621-fedex-plus-1_9-percent-on-buyback-news?source=tweet\" data-url=\"https://seekingalpha.com/news/1492621-fedex-plus-1_9-percent-on-buyback-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492591\" data-ts=\"1389017461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492591-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/SEED\" title=\"Origin Agritech Limited\">SEED</a> <font color=\"green\">+29%</font>. PPHM <font color=\"green\">+28%</font>. EONC <font color=\"green\">+18%</font>. OXBT <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/CBMX\" title=\"CombiMatrix Corporation\">CBMX</a> <font color=\"green\">+13%</font>. SCTY <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/XPO\" title=\"XPO Logistics, Inc\">XPO</a> <font color=\"green\">+10%</font>. ETRM <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/RMBS\" title=\"Rambus, Inc.\">RMBS</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/GRO\" title=\"Agria Corporation\">GRO</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/PACR\" title=\"Pacer International, Inc.\">PACR</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/SIRI\" title=\"Sirius XM Holdings Inc.\">SIRI</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/PXLW\" title=\"Pixelworks, Inc.\">PXLW</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/LIVE\" title=\"Live Ventures\">LIVE</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/ATHX\" title=\"Athersys, Inc.\">ATHX</a> <font color=\"green\">+7%</font>. RSOL <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/P\" title=\"Pandora Media\">P</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/CPST\" title=\"Capstone Turbine Corporation\">CPST</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/FRO\" title=\"Frontline Ltd.\">FRO</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"green\">+5%</font>.</li>\n<li>\n<b>Losers:</b> SCSS <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/GYRO\" title=\"Gyrodyne, LLC\">GYRO</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/CAMT\" title=\"Camtek Ltd.\">CAMT</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/CHTP\" title=\"Chelsea Therapeutics International, Ltd.\">CHTP</a> <font color=\"red\">-5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492591\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$SEED $CDMO $INVT - Premarket Gainers / Losers https://seekingalpha.com/news/1492591-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1492591-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492561\" data-ts=\"1389017402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBMX\" target=\"_blank\">CBMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492561-combimatrix-up-double-digits-before-the-bell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CombiMatrix up double-digits before the bell</a></h4><ul>\n<li>Shares of CombiMatrix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CBMX\" title=\"CombiMatrix Corporation\">CBMX</a>) are higher by <font color=\"green\">13%</font> premarket.</li>\n<li>Investors are likely cheering news out late last week that Longwood Capital has <a href=\"https://seekingalpha.com/news/1491521-CombiMatrix-plus-3_9-percent-AH-Longwood-Capital-discloses-5_1-percent-stake\" target=\"_blank\">taken a 5.1% stake</a> in the company.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492561\" data-linked=\"CombiMatrix up double-digits before the bell\" data-tweet=\"$CBMX - CombiMatrix up double-digits before the bell https://seekingalpha.com/news/1492561-combimatrix-up-double-digits-before-the-bell?source=tweet\" data-url=\"https://seekingalpha.com/news/1492561-combimatrix-up-double-digits-before-the-bell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492531\" data-ts=\"1389016974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTIC\" target=\"_blank\">CTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492531-cell-therapeutics-rallies-on-nice-nod-for-pixuvri\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cell Therapeutics rallies on NICE nod for Pixuvri</a></h4><ul>\n<li>Cell Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a>) rises <font color=\"green\">3%</font> premarket.</li>\n<li>U.K. cost gatekeeper NICE has issued a positive final draft opinion on Pixuvri.</li>\n<li>The regulator \"recommends funding the treatment as a monotherapy for the treatment of  adult patients with multiply relapsed or refractory aggressive B-cell  non-Hodgkin lymphoma,\" the company says.</li>\n<li>Here's CEO James Bianco: \"[This] means that physicians in England and Wales now have access to the only approved therapy for their patients with aggressive B-cell NHL in the third- and fourth-line salvage setting.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492531\" data-linked=\"Cell Therapeutics rallies on NICE nod for Pixuvri\" data-tweet=\"$CTIC - Cell Therapeutics rallies on NICE nod for Pixuvri https://seekingalpha.com/news/1492531-cell-therapeutics-rallies-on-nice-nod-for-pixuvri?source=tweet\" data-url=\"https://seekingalpha.com/news/1492531-cell-therapeutics-rallies-on-nice-nod-for-pixuvri\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492501\" data-ts=\"1389016580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TENX\" target=\"_blank\">TENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492501-oxygen-biotherapeutics-announces-publication-of-levosimendan-trial-outline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oxygen Biotherapeutics announces publication of levosimendan trial outline</a></h4><ul>\n<li>Oxygen Biotherapeutics (OXBT) is <font color=\"green\">6.5%</font> higher premarket.</li>\n<li>The company announced this morning that the Phase 3 trial protocol for <a href=\"https://seekingalpha.com/news/search?query=levosimendan\" target=\"_blank\">levosimendan</a> has been published at clinicaltrials.gov.</li>\n<li>Here's CEO John Kelley: \"We look forward to enrolling the first patients in this important       trial later this year.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492501\" data-linked=\"Oxygen Biotherapeutics announces publication of levosimendan trial outline\" data-tweet=\"$TENX - Oxygen Biotherapeutics announces publication of levosimendan trial outline https://seekingalpha.com/news/1492501-oxygen-biotherapeutics-announces-publication-of-levosimendan-trial-outline?source=tweet\" data-url=\"https://seekingalpha.com/news/1492501-oxygen-biotherapeutics-announces-publication-of-levosimendan-trial-outline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492471\" data-ts=\"1389016438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492471-aig-upgraded-to-buy-at-credit-suisse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AIG upgraded to Buy at Credit Suisse</a></h4><ul>\n<li>Following a 6-month research restriction, <a href=\"https://seekingalpha.com/symbol/AIG\" title=\"American International Group Inc\">AIG</a> is upgraded to Buy with $59 price target at Credit Suisse. The team had previously seen the stock as cheap vs. book value, but not vs. earnings. \"While we believe that consensus EPS estimates are still optimistic, we believe the current valuation embeds something worse following management backing off its 2015 ROE goal.\"</li>\n<li>The team expects AIG will fare best among insurers when put through the Fed stress test for the first time (2015 at earliest). Thanks to the ILFC sale, CS wouldn't be surprised if AIG boosts its capital return plans before the CCAR process.</li>\n<li>Shares <font color=\"green\">+1.2%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492471\" data-linked=\"AIG upgraded to Buy at Credit Suisse\" data-tweet=\"$AIG - AIG upgraded to Buy at Credit Suisse https://seekingalpha.com/news/1492471-aig-upgraded-to-buy-at-credit-suisse?source=tweet\" data-url=\"https://seekingalpha.com/news/1492471-aig-upgraded-to-buy-at-credit-suisse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492461\" data-ts=\"1389016278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492461-mast-therapeutics-rallies-on-heart-failure-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mast Therapeutics rallies on heart failure data</a></h4><ul>\n<li>Mast Therapeutics (MSTX) is up<font color=\"green\"> 12%</font> in early action.</li>\n<li>The company says MST-188 \"demonstrated a statistically significant improvement in numerous parameters of heart function,\" in a nonclinical heart failure model.</li>\n<li>The data collected suggest the treatment may be promising way to improve left ventricular ejection fraction and end-systolic volume.</li>\n<li>The company intends to \"provide an update on its plans for MST-188 in heart failure later in 2014.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492461\" data-linked=\"Mast Therapeutics rallies on heart failure data\" data-tweet=\"$SVRA - Mast Therapeutics rallies on heart failure data https://seekingalpha.com/news/1492461-mast-therapeutics-rallies-on-heart-failure-data?source=tweet\" data-url=\"https://seekingalpha.com/news/1492461-mast-therapeutics-rallies-on-heart-failure-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492431\" data-ts=\"1389016019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492431-catalyst-pharma-jumps-after-firdapse-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma jumps after Firdapse update</a></h4><ul>\n<li>Catalyst Pharmaceutical (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a>) is higher by <font color=\"green\">10%</font> in premarket action.</li>\n<li>The company says it has completed a Type B meeting with the FDA regarding the LEMS treatment <a href=\"https://seekingalpha.com/news/search?query=firdapse\" target=\"_blank\">Firdapse</a>.</li>\n<li>CPRX says it updated the regulator on the drug's development program and \"confirmed ... the clinical, nonclinical, and chemistry and manufacturing controls requirements that FDA will require to approve an NDA.\"</li>\n<li>The company notes that after discussing \"the acceptability of the primary and secondary endpoints specified in the protocol for the ongoing Phase 3 trial, the FDA requested a slight modification in the analyses to be conducted for the endpoints.\" CPRX does not see this as changing the data being collected and should not alter the number of patients \"needed to complete enrollment.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492431\" data-linked=\"Catalyst Pharma jumps after Firdapse update\" data-tweet=\"$CPRX - Catalyst Pharma jumps after Firdapse update https://seekingalpha.com/news/1492431-catalyst-pharma-jumps-after-firdapse-update?source=tweet\" data-url=\"https://seekingalpha.com/news/1492431-catalyst-pharma-jumps-after-firdapse-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492391\" data-ts=\"1389015544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIRI\" target=\"_blank\">SIRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492391-investors-enthusiastic-over-sirius-xm-radio\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors enthusiastic over Sirius XM Radio</a></h4><ul>     <li>Shares of Sirius XM Radio (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SIRI\" title=\"Sirius XM Holdings Inc.\">SIRI</a>) race <font color=\"green\">7.8% higher</font> to $3.85 in premarket trading following an <a href=\"https://seekingalpha.com/news/1491431-Liberty-Media-proposes-to-assume-full-ownership-of-Sirius-XM\" target=\"_blank\">offer</a> late Friday from Liberty Media (LMCA) to take over the company in a deal which values the company at $3.68 per share.</li>     <li>In a conference call with analysts, execs said if the deal is completed it would allow Liberty to start buying back shares at an increased pace.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1492391\" data-linked=\"Investors enthusiastic over Sirius XM Radio\" data-tweet=\"$SIRI $SIRI $FWONA - Investors enthusiastic over Sirius XM Radio https://seekingalpha.com/news/1492391-investors-enthusiastic-over-sirius-xm-radio?source=tweet\" data-url=\"https://seekingalpha.com/news/1492391-investors-enthusiastic-over-sirius-xm-radio\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492371\" data-ts=\"1389015454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492371-peregrine-pharma-rallies-on-fast-track-designation-for-bavituximab\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peregrine Pharma rallies on Fast Track designation for bavituximab</a></h4><ul>\n<li>Peregrine Pharmaceuticals (PPHM) soars <font color=\"green\">33%</font> premarket.<br>\n</li>\n<li>The company has landed Fast Track designation for <a href=\"https://seekingalpha.com/news/search?query=bavituximab\" target=\"_blank\">bavituximab</a> in NSCLC.</li>\n<li>Pivotal trial (<a href=\"https://seekingalpha.com/news/1485311-Peregrine-Pharma-starts-Phase-3-immunotherapy-trial-in-lung-cancer\" target=\"_blank\">SUNRISE</a>) is underway. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492371\" data-linked=\"Peregrine Pharma rallies on Fast Track designation for bavituximab\" data-tweet=\"$CDMO - Peregrine Pharma rallies on Fast Track designation for bavituximab https://seekingalpha.com/news/1492371-peregrine-pharma-rallies-on-fast-track-designation-for-bavituximab?source=tweet\" data-url=\"https://seekingalpha.com/news/1492371-peregrine-pharma-rallies-on-fast-track-designation-for-bavituximab\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492311\" data-ts=\"1389014506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492311-citi-negative-on-sarepta-ariad-for-2014-shares-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi negative on Sarepta, Ariad for 2014, shares slide</a></h4><ul>\n<li>Shares of Sarepta Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a>) are off<font color=\"red\"> 5.7%</font> premarket.</li>\n<li>Likely behind the move is Citi, where SRPT is <a href=\"https://twitter.com/adamfeuerstein/status/420170704697315328/photo/1\" target=\"_blank\">a top sell idea for 2014</a>, along with Ariad Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a>).</li>\n<li>On SRPT, Citi doesn't \"anticipate that [the] FDA will reverse its view that eteplirsen's Phase 2 data is not sufficient to file [making] the path ahead ... risky, lengthy, and expensive.\"</li>\n<li>On ARIA: \"We expect the [Iclusig] re-launch to be challenging with a tightly restricted label and headwinds.\"</li>\n<li>ARIA <font color=\"red\">-6.5%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492311\" data-linked=\"Citi negative on Sarepta, Ariad for 2014, shares slide\" data-tweet=\"$SRPT $SRPT $ARIA - Citi negative on Sarepta, Ariad for 2014, shares slide https://seekingalpha.com/news/1492311-citi-negative-on-sarepta-ariad-for-2014-shares-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/1492311-citi-negative-on-sarepta-ariad-for-2014-shares-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492201\" data-ts=\"1389013056\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492201-twitter-cut-to-sell-at-morgan-stanley-off-4-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter cut to sell at Morgan Stanley; off 4% premarket</a></h4><ul>\n<li>With the competition for online advertising revenue intensifying, TV ad budgets are more likely to go to YouTube and Facebook first, rather than smaller platforms like Twitter (NYSE:<a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a>), says Morgan Stanley, <a href=\"https://pbs.twimg.com/media/BdTCcQTCMAAiIzN.jpg:large\" target=\"_blank\">downgrading the stock</a> to Sell.</li>\n<li>The price target of $33, notes the team, would have the stock trading at 14x revenue and 84x 2015 estimated EBITDA.</li>\n<li>\"Where we could be wrong\": Near-term estimates may be conservative, says the team, meaning revisions following late January/early February Q4 results could provide a near-term boost to the stock.</li>\n<li>Shares <font color=\"red\">-4.1%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492201\" data-linked=\"Twitter cut to sell at Morgan Stanley; off 4% premarket\" data-tweet=\"$TWTR - Twitter cut to sell at Morgan Stanley; off 4% premarket https://seekingalpha.com/news/1492201-twitter-cut-to-sell-at-morgan-stanley-off-4-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1492201-twitter-cut-to-sell-at-morgan-stanley-off-4-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492171\" data-ts=\"1389012212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492171-apple-cut-to-sell-at-standpoint-over-moral-reasons\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple cut to Sell at Standpoint over moral reasons</a></h4><ul>\n<li>\"For Apple (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a>) to pay their workers $2 an hour while they have $150B in the bank is nothing short of obscene,\" writes analyst Ronnie Moas, <a href=\"http://www.streetinsider.com/Downgrades/Standpoint+Research+Downgrades+Apple+%28AAPL%29+to+Sell+for+Moral+Reasons/9024630.html\" target=\"_blank\">downgrading the stock to a Sell</a>. \"Instead of treating their employees like human beings, they are treated like animals. If it were not for their employees, Apple would not be where it is today.\"</li>\n<li>The stock's <font color=\"red\">off 0.8%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492171\" data-linked=\"Apple cut to Sell at Standpoint over moral reasons\" data-tweet=\"$AAPL - Apple cut to Sell at Standpoint over moral reasons https://seekingalpha.com/news/1492171-apple-cut-to-sell-at-standpoint-over-moral-reasons?source=tweet\" data-url=\"https://seekingalpha.com/news/1492171-apple-cut-to-sell-at-standpoint-over-moral-reasons\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>140&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492161\" data-ts=\"1389012133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XPO\" target=\"_blank\">XPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492161-xpo-to-acquire-pacer-for-335m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XPO to acquire Pacer for $335M</a></h4><ul>   <li>XPO Logistics (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/XPO\" title=\"XPO Logistics, Inc\">XPO</a>) has <a href=\"http://www.reuters.com/article/2014/01/06/pacer-offer-idUSL3N0KG2LA20140106\" target=\"_blank\">agreed to acquire</a> Pacer International (<a href=\"https://seekingalpha.com/symbol/PACR\" title=\"Pacer International, Inc.\">PACR</a> <font color=\"green\">+3.2%</font>) for $335M in cash and stock, well above the latter's market cap of $294.3M at the close of trade on Friday.</li>    <li>Pacer is North America's third-largest provider of intermodal services, which move goods in containers between different forms of transport such as truck, train and ship.</li>    <li>XPO expects the acquisition to double its annual revenues to around $2B. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1492161\" data-linked=\"XPO to acquire Pacer for $335M\" data-tweet=\"$XPO $XPO $PACR - XPO to acquire Pacer for $335M https://seekingalpha.com/news/1492161-xpo-to-acquire-pacer-for-335m?source=tweet\" data-url=\"https://seekingalpha.com/news/1492161-xpo-to-acquire-pacer-for-335m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1492151\" data-ts=\"1389011557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1492151-solarcity-makes-goldman-conviction-buy-list-plus-7-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarCity makes Goldman Conviction Buy list; +7% premarket</a></h4><ul>\n<li>There's more value than meets the eye, <a href=\"https://twitter.com/thenotablecalls/status/420165105901260800\" target=\"_blank\">says Goldman</a>, and a near-term valuation of $100 per share is achievable.</li>\n<li>SCTY is <font color=\"green\">ahead 7%</font> to $63.45 in premarket action.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1492151\" data-linked=\"SolarCity makes Goldman Conviction Buy list; +7% premarket\" data-tweet=\"$TSLA - SolarCity makes Goldman Conviction Buy list; +7% premarket https://seekingalpha.com/news/1492151-solarcity-makes-goldman-conviction-buy-list-plus-7-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1492151-solarcity-makes-goldman-conviction-buy-list-plus-7-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1491961\" data-ts=\"1389004345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1491961-japan-leads-asian-stocks-lower-europe-mixed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Japan leads Asian stocks lower, Europe mixed</a></h4><ul>   <li>Asian shares tilt lower and European equities are mixed, while U.S. stock futures are flat-to-higher.</li>    <li>Japan's Nikkei <font color=\"red\">sank 2.35%</font> on the <a href=\"http://online.wsj.com/article/SB10001424052702304617404579303183219701734.html\" target=\"_blank\">first day of trading</a> of 2014, although that was off the back of a nine-day winning streak prior to the New Year break.  \"A consolidation move of some kind was in order for stocks after that long nine-day run up,\" says asset manager Yoshihiro Okumura. \"The magnitude of the fall is understandable considering the dollar's weakness.\"</li>    <li>The Shanghai composite <font color=\"red\">dropped 1.8%</font>, pulled lower by slowing services growth, the re-opening of the IPO market and concern about how government reform might affect GDP.</li>    <li>In Europe, <a href=\"http://www.reuters.com/article/2014/01/06/markets-europe-stocks-open-idUSL6N0KG0I120140106\" target=\"_blank\">Spanish shares</a> <font color=\"green\">climbed 0.7%</font> following strong PMI data. Elsewhere, London is <font color=\"red\">-0.2%</font>, Paris flat, Frankfurt <font color=\"red\">-0.1%</font>, Milan <font color=\"green\">+0.7%</font> and the the EU Stoxx 50 is <font color=\"green\">+0.1%</font>.</li>     <li>U.S. stock futures: Dow <font color=\"green\">+0.1%</font>. S&amp;P <font color=\"green\">+0.1%</font>. Nasdaq <font color=\"green\">+0.1%</font>\n</li>\n<li>Japan ETFs: <a href=\"https://seekingalpha.com/symbol/dxj\" title=\"WisdomTree Japan Hedged Equity ETF\">DXJ</a>, <a href=\"https://seekingalpha.com/symbol/ewj\" title=\"iShares MSCI Japan ETF\">EWJ</a>, <a href=\"https://seekingalpha.com/symbol/dfj\" title=\"WisdomTree Japan SmallCap Dividend ETF\">DFJ</a>, <a href=\"https://seekingalpha.com/symbol/nky\" title=\"Precidian MAXIS Nikkei 225 Index ETF\">NKY</a>, <a href=\"https://seekingalpha.com/symbol/dbjp\" title=\" db X-trackers MSCI Japan Hedged Equity Fund ETF\">DBJP</a>, <a href=\"https://seekingalpha.com/symbol/ezj\" title=\"ProShares Ultra MSCI Japan ETF\">EZJ</a>, <a href=\"https://seekingalpha.com/symbol/ewv\" title=\"ProShares UltraShort MSCI Japan ETF\">EWV</a>, <a href=\"https://seekingalpha.com/symbol/scj\" title=\"iShares MSCI Japan Small-Cap ETF\">SCJ</a>, <a href=\"https://seekingalpha.com/symbol/jsc\" title=\"SPDR Russell/Nomura Small Cap Japan ETF\">JSC</a>, <a href=\"https://seekingalpha.com/symbol/dxjs\" title=\"WisdomTree Japan Hedged SmallCap Equity ETF\">DXJS</a>, <a href=\"https://seekingalpha.com/symbol/itf\" title=\"iShares Japan Large-Cap ETF\">ITF</a>, <a href=\"https://seekingalpha.com/symbol/jpp\" title=\"SPDR Russell/Nomura PRIME Japan ETF\">JPP</a>, <a href=\"https://seekingalpha.com/symbol/jpnl\" title=\"Direxion Daily Japan Bull 3x Shares ETF\">JPNL</a>, <a href=\"https://seekingalpha.com/symbol/jpns\" title=\"Direxion Daily Japan Bear 3x Shares ETF\">JPNS</a>, <a href=\"https://seekingalpha.com/symbol/fjp\" title=\"First Trust Japan AlphaDEX ETF\">FJP</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1491961\" data-linked=\"Japan leads Asian stocks lower, Europe mixed\" data-tweet=\"$DXJ $EWJ $DFJ - Japan leads Asian stocks lower, Europe mixed https://seekingalpha.com/news/1491961-japan-leads-asian-stocks-lower-europe-mixed?source=tweet\" data-url=\"https://seekingalpha.com/news/1491961-japan-leads-asian-stocks-lower-europe-mixed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1491851\" data-ts=\"1388994354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1491851-fall-in-chinese-services-pmi-indicates-slowdown-is-broadbased\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fall in Chinese services PMI indicates slowdown is broadbased</a></h4><ul>   <li>Chinese HSBC services PMI <a href=\"http://www.reuters.com/article/2014/01/06/us-china-economy-services-pmi-idUSBREA0503Y20140106\" target=\"_blank\">dropped to the lowest</a> level since August 2011, falling to 50.9 in December from 52.5 in November.</li>    <li>The decline mirrors a drop in the <a href=\"https://seekingalpha.com/news/1489861-Chinas-services-sector-growth-eases\" target=\"_blank\">official print</a> to 54.6 from 56, as well a deceleration in manufacturing growth, and suggests that the slowdown in the economy is broad-based.</li>    <li>The sub-index for new business orders sank to a six-month low of 51.8, although labor conditions improved.</li>    <li>HSBC put a positive spin on the data, saying it expects that the expansion in manufacturing and that economic reform will support the services sector.</li>    <li>Still, the reading helped drag down Asian markets amid fears that China's slowdown will continue in Q1.</li>    <li>The Shanghai Composite <font color=\"red\">-1.8%</font>, Hang Seng <font color=\"red\">-0.4%</font>, Japan <font color=\"red\">-2.35%</font>, India <font color=\"red\">-0.3%</font>. (PR)</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/fxi\" title=\"iShares China Large-Cap ETF\">FXI</a>, <a href=\"https://seekingalpha.com/symbol/pgj\" title=\"PowerShares Golden Dragon China Portfolio ETF\">PGJ</a>, <a href=\"https://seekingalpha.com/symbol/gxc\" title=\"SPDR S&amp;P China ETF\">GXC</a>, <a href=\"https://seekingalpha.com/symbol/fxp\" title=\"ProShares UltraShort FTSE China 25 ETF\">FXP</a>, <a href=\"https://seekingalpha.com/symbol/hao\" title=\"Guggenheim China Small Cap ETF \">HAO</a>, <a href=\"https://seekingalpha.com/symbol/cyb\" title=\"WisdomTree Chinese Yuan ETF\">CYB</a>, <a href=\"https://seekingalpha.com/symbol/yinn\" title=\"Direxion Daily FTSE China Bull 3X Shares ETF\">YINN</a>, <a href=\"https://seekingalpha.com/symbol/cny\" title=\"Market Vectors Chinese Renminbi/USD ETN\">CNY</a>, <a href=\"https://seekingalpha.com/symbol/tao\" title=\"Guggenheim China Real Estate ETF \">TAO</a>, <a href=\"https://seekingalpha.com/symbol/chiq\" title=\"Global X China Consumer ETF\">CHIQ</a>, <a href=\"https://seekingalpha.com/symbol/chix\" title=\"Global X China Financial ETF\">CHIX</a>, <a href=\"https://seekingalpha.com/symbol/ashr\" title=\"db X-trackers Harvest China ETF\">ASHR</a>, <a href=\"https://seekingalpha.com/symbol/mchi\" title=\"iShares MSCI China ETF\">MCHI</a>, <a href=\"https://seekingalpha.com/symbol/yang\" title=\"Direxion Daily FTSE China Bear 3x Shares ETF\">YANG</a>, <a href=\"https://seekingalpha.com/symbol/pek\" title=\"Market Vectors China ETF \">PEK</a>, <a href=\"https://seekingalpha.com/symbol/cqqq\" title=\"Guggenheim China Technology ETF \">CQQQ</a>, <a href=\"https://seekingalpha.com/symbol/dsum\" title=\"PowerShares Chinese Yuan Dim Sum Bond Portfolio ETF\">DSUM</a>, <a href=\"https://seekingalpha.com/symbol/xpp\" title=\"ProShares Ultra FTSE China 25 ETF\">XPP</a>, <a href=\"https://seekingalpha.com/symbol/qqqc\" title=\"Global X China Technology ETF\">QQQC</a>, <a href=\"https://seekingalpha.com/symbol/yao\" title=\"Guggenheim China All-Cap ETF \">YAO</a>, <a href=\"https://seekingalpha.com/symbol/kweb\" title=\"KraneShares CSI China Internet ETF\">KWEB</a>, <a href=\"https://seekingalpha.com/symbol/chxx\" title=\"EGShares China Infrastructure ETF\">CHXX</a>, <a href=\"https://seekingalpha.com/symbol/chii\" title=\"Global X China Industrial ETF\">CHII</a>, <a href=\"https://seekingalpha.com/symbol/fxch\" title=\"CurrencyShares Chinese Renminbi Trust ETF\">FXCH</a>, <a href=\"https://seekingalpha.com/symbol/ecns\" title=\"iShares MSCI China Small-Cap ETF\">ECNS</a>, <a href=\"https://seekingalpha.com/symbol/chxf\" title=\"WisdomTree China Dividend ex-Financials ETF\">CHXF</a>, <a href=\"https://seekingalpha.com/symbol/chie\" title=\"Global X China Energy ETF\">CHIE</a>, <a href=\"https://seekingalpha.com/symbol/yxi\" title=\"ProShares Short FTSE China 25 ETF\">YXI</a>, <a href=\"https://seekingalpha.com/symbol/chim\" title=\"Global X China Materials ETF\">CHIM</a>, <a href=\"https://seekingalpha.com/symbol/kfyp\" title=\"KraneShares CSI China Five Year Plan ETF\">KFYP</a>, <a href=\"https://seekingalpha.com/symbol/fca\" title=\"First Trust China AlphaDEX ETF\">FCA</a>, <a href=\"https://seekingalpha.com/symbol/tchi\" title=\"RBS China Trendpilot ETN\">TCHI</a>, <a href=\"https://seekingalpha.com/symbol/chlc\" title=\"Market Vectors Renminbi Bond ETF\">CHLC</a>, <a href=\"https://seekingalpha.com/symbol/chna\" title=\"PowerShares China A - Share Portfolio ETF\">CHNA</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1491851\" data-linked=\"Fall in Chinese services PMI indicates slowdown is broadbased\" data-tweet=\"$FXI $PGJ $GXC - Fall in Chinese services PMI indicates slowdown is broadbased https://seekingalpha.com/news/1491851-fall-in-chinese-services-pmi-indicates-slowdown-is-broadbased?source=tweet\" data-url=\"https://seekingalpha.com/news/1491851-fall-in-chinese-services-pmi-indicates-slowdown-is-broadbased\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":68,"message":null,"success":true,"today":{"start":1576904400,"end":1576990799,"str":"Saturday, December 21, 2019"},"yesterday":{"start":1576818000,"end":1576904399}}